The Geneva Learning Foundation (TGLF) publishes this transcript so that health workers, ministries of health and other stakeholders can read what was said at the first candidates’ forum for the election of the next Director-General of the World Health Organization (WHO). It covers the first day of the forum, 18 November 2026, when Member States interviewed four of the seven candidates: Dr Hanan Mohammed Al-Kuwari, Dr Hans Henri P. Kluge, Dr Gevorg Tamamyan and Dr Li Song. We could not find an official transcript online, so we prepared this clean verbatim version from the English audio channel of the public webcast. Two days before the forum, TGLF sent the candidates From guidance to results, an agenda paper available in the six official languages of the United Nations. It sets out six proposals for WHO to operate as a two-way learning system, in which guidance reaches the people who deliver health services and what they learn in applying it returns to their peers, their ministry and WHO. Our feature article explains what ten years of work with community-based health workers suggests the new Director-General should do. It also notes that every candidate has promised results that people can see in countries. Read alongside these two documents, the transcript shows how each candidate answered Member States’ questions about turning that promise into practice.
Morning session
CHAIR: Ladies and gentlemen, it is with great pleasure that I welcome you to the First Candidates Forum for the election of Director-General of World Health Organization. The first candidates forum has been convened in accordance with Rule 62 of the Rules of Procedure of Executive Board and Resolution WHA 66.18, as amended through decision WHA 73.27. The Candidates Forum is a non-decision-making platform for candidates to make themselves and their vision known to Member States on an equal basis. The detailed arrangements for the conduct of the interviews at the First Candidates Forum were approved by Executive Board in Decision EB159-3. Participation in the Candidates Forum is limited to representatives of Member States and associate members, and a limited number of secretariat staff.
Participants from Member States and associate members are seated according to their respective regional membership. Candidates will be escorted to the auditorium shortly before their interview. The candidates forum is also being webcast on WHO website in all official languages. Arrangement for interviews. Let us now turn to the arrangements for interviews.
As you know, the Health Assembly and Executive Board decided that each candidate will make a presentation of up to 10 minutes, followed by a question and answer session of up to 50 minutes, with the overall duration of each interview remaining maximum to 60 minutes. The order of the interview was drawn by lot on 8th October in the presence of a representative of each of the nominating Member States. Accordingly, the program of the Candidates Forum is as follows: During this morning’s session, the first interview will be that of Dr Hanan Mohammed Al-Kuwari, by the interview of Dr Hans Henri P. Kluge. The Candidates Forum will continue this afternoon with the interview of Dr Gevorg Tamamyan, followed by the interview of Dr Li Song.
Tomorrow morning’s session will open with the interview of Mr Budi Gunadi Sadikin, to be followed by interview of Dr María Neira. Tomorrow’s afternoon session will conclude the forum with the interview of Dr Hanan Balkhy, the order of the interview is listed in the program for the candidates forum that was sent electronically to all the Member States on 5th November. Oral presentation. Regarding the oral presentation, candidates will have up to 10 minutes for their presentation. Candidates may, of course, choose to speak or speak for less than 10 minutes.
However, the time left will not be added to the question and answer session. Question and answer session. After the presentation by the candidate, we will turn to the question and answer session. As far as the process for selecting question is concerned, each Member States and associate members present will be given a color-coded token of each candidate to be interviewed. Bearing the member and candidate’s name.
The token will be delivered at the outset of each morning and afternoon session. The token will be… Sorry. You should therefore have already received the two tokens relating to the candidates to be interviewed this morning. Colors have been assigned to seven candidates by drawing of lots as follows.
The blue token for Dr Hanan Mohammed Al-Kuwari. The orange token for Dr Hans Henri P. Kluge. The white token for Dr Gevorg Tamamyan. The green token for Dr Li Song. The yellow token for Dr Budi Gunadi Sadikin, the purple token for Dr María Neira, the grey token for Dr Hanan Balkhy. The Member States and associate members will be invited to indicate whether they wish to ask the candidate a question by placing their token in one of the six receptacles that will be circulated around, one for each region. Please ensure to fold your token once before placing in the receptacle. Finally, note that in the event that a delegation has placed in the receptacle a token corresponding to a candidate other than one being interviewed, that a token will be ignored. And I will proceed with pulling another token from the same receptacle.
Once all tokens have been collected, I will pull one token from each receptacle following the order of regions previously determined by lot. For the first candidate to be interviewed, the first region drawn will have the first opportunity to pose a question, followed by other regions in the order drawn. For the second interview, we will begin with the second region drawn and so on, rotating the starting region for each successive interview until the close of the forum. Once six tokens, one per region, have been pulled out, the corresponding Member States or associate members will be invited to ask a question. In this way, it will be assured that first six questions will each come from different regions.
After six questions, one from each region has been asked. The contents of the six receptacles will be merged into one, and the selection of those invited to ask questions will continue one by one on a fully random basis until the time available is exhausted. Member States and associate members will have up to one minute to ask questions only. Please do not divide questions into different parts such that there is, in effect, more than one question. I would ask that Member States whose lot have been drawn and are therefore provided the opportunity to ask questions kindly refrain from posing a question to a candidate which seems identical or substantially similar to one already addressed to the candidate.
Candidates will have up to three minutes to respond to each question. I would also seek the indulgence of those Member States that have nominated one of the seven candidates to refrain from asking a question of that candidate. Commencement of time periods and traffic light system. The time period for the interview will come in when the candidate is given the floor for her or his presentation. Should the candidate wish to use a PowerPoint presentation and experience any technical difficulties with that, he or she may ask the timer to be paused.
The time period for the question and answer session will commence when the first question is read out. Each interview will conclude when the 60 minutes for the interview have eclipse, even if there are still questions pending. However, a candidate will be permitted to complete their answers to the question being addressed when the 60 minutes eclipse. Should there still be time available when the questions have been exhausted, the candidates may, if he or she wishes, make additional remarks within the remaining time. Please note that I will ask both Member States and Associate Members, as well as candidates, to strictly adhere to the time limits for questions and answers.
After the allotted time is eclipsed, you will have 20 seconds to conclude, after which the microphone will be automatically cut. The first system will monitor two traffic light systems have been installed to assess all participants in adhering to the aggregate time limits for presentation and response to the questions. The first system will monitor both 10-minute presentation period and 50-minute question and answer session period. An amber light will be displayed within two minutes in the presentation period and five minutes remain in the question and answer session. The second system will monitor the one-minute period allotted for question and three-minute period allotted for response.
An amber light will be displayed when 30 seconds remain for the question and when one minute remains for the response. An audible signal will sound when the light turns amber, and the second signal will sound when the allotted time has expired. Once the allotted time has expired, I shall invite the speaker to bring their presentation for response to close. The traffic light systems will be stopped while the color-coded tokens are being collected, as well as when the tokens in six receptacles are being merged into one. Because of this strict time limit, I will ask all delegations not to interrupt the interview process by taking the floor unless this is a point of order dealing with the conduct of the interview.
Are there any questions? No? I see none. So I see there are no further questions. Before proceeding with the first interview, we will proceed with the drawing of lots to determine the order in which Regents will have the opportunity for one of its members to ask a question during the question and answer session.
SECRETARY: First is the African region. Second is the Eastern Mediterranean region. Third is the region of the Americas. Fourth is the European region. Fifth is the Western Pacific region.
CHAIR: I can’t predict this.
SECRETARY: You can guess, yes. I hope it is. And finally, Southeast Asia region.
CHAIR: This is done, no? No. Yes.
SECRETARY: But you can read this. Southeast Asia.
CHAIR: I thought this issue was last, no?
SECRETARY: Southeast Asia was second last. Oh, sorry, yes, yes, it was. Southeast Asia was last, but we have seven, so we start again with the first one for number seven. Okay.
CHAIR: Now, since we have drawn accordingly the region that will have the first opportunity to pose a question during the interview of Dr Hanan Mohammed Al-Kuwari is followed by African region. The region that will have the first opportunity to pose a question during the interview of Dr Hans Henri P. Kluge, followed by Eastern Mediterranean Region, the region that will have the opportunity to pose a question during the interview of Dr Gevorg Tamamyan, the Americas. The region that will have the first opportunity to pose a question during the interview of Dr Li Song is followed by Europe, the region that will have the first opportunity to pose a question during the interview of Dr Budi Gunadi Sadikin, followed by Western Pacific, the region that will have the first opportunity to pose a question during the interview of Dr María Neira is followed by Southeast Asia region.
The region that will have the first opportunity to pose a question during the interview of Dr Hanan Balkhy is followed by the African region. TAM table and mobile phone. The working hours will be 9.30 to 12.30 and 14 hours till 17 hours. Before we proceed, a vote on mobile phone. You are kindly requested to switch your mobile phone to vibrate or meeting mode and to avoid using them in the room.
Please note that even when the phone is not in use but switched on, it can interfere with the electrical equipment. So, please do not place it near the microphone or earphone. Before proceeding with the first interview, may I please verify that all delegations have received the envelope with two tokens for this morning session. If you have not received, please raise your hands. Everyone seems to have received.
I see that the delegation, all the delegations have received. So I shall ask the Secretary to bring in the first candidate, Dr Hanan Mohammed Al-Kuwari, to the room. Obrigado. Good morning, Dr Hanan Mohammed Al-Kuwari. Welcome to the First Candidates Forum for the election of Director-General.
I wish to thank you for coming to this interview today. I understand that the Secretary has already informed you the way we shall proceed this morning, and I propose that we start immediately with your oral presentation. Should you experience any technical difficulties with your presentation, please ask the timer to be paused, if you have PowerPoint presentation. So you have the floor. The 10-minute period will begin simultaneously with the activation of the lighting system.
Interview of Dr Hanan Mohammed Al-Kuwari
DR HANAN MOHAMMED AL-KUWARI: Thank you, Mr Chairman. Good morning, everyone. Assalamu alaikum wa rahmatullahi wa barakatuh. Bonjour. Your Excellencies, ladies and gentlemen, the world needs WHO and nothing can replace it.
When Member States founded the World Health Organization, they gave it a role no other institution holds, to act as the directing and coordinating authority on international health work, with the objective of the attainment of all people of the highest possible level of health. They also stated the principle that remains strikingly current, that the health of all peoples is fundamental to the attainment of peace and security and is dependent upon the fullest cooperation of individuals and of states. That cooperation is now under strain. Wars are destroying health systems. Epidemics and climate shocks cross borders faster than institutions can respond, and the multilateral system is fragmenting.
Yet health remains one of the few fields in which countries still work together across political divides, and WHO is the only place where all of them sit as equals, regardless of size, income or power. I am running for the position of Director-General because I believe health can be where multilateralism is relaunched and because WHO must be strong enough to lead that effort. I wish to thank my country for their support in nominating me and their trust in nominating me, as well as my region for their support. My purpose, Your Excellencies, is not to administer an institution, but to help it do what no other body can, that is, to unite the world for our health. WHO’s most serious problem is a loss of trust among governments and among citizens.
In my meetings with Member States, this was raised in every region. Its causes are well known to us. Guidance during COVID-19 that was perceived as slow or inconsistent. Financing that is fragile and tied to the priorities of a few contributors. A budget many Member States find hard to read and fully understand.
A sense that some countries count more than others, and the departures of members. All of this weakens the organization for everyone. A health authority that is not trusted cannot protect health, however sound its sciences. Trust, your excellencies, is built by process, not by assertions. I would extend the transparency that already governs WHO’s guidelines to emergency and interim guidance, where trust is tested hardest.
I would propose independent oversight of the integrity of WHO’s scientific advice. I would carry out a thorough financial analysis and publish yearly a simple dashboard of budget, spending and results. I will also make sure every country is heard, irrespective of its size or wealth. WHO’s door will remain open to every country that wishes to rejoin. And I will speak for the protection of healthcare in every conflict with the same method and same conviction.
My vision, Your Excellencies, a healthier, fairer, better prepared world rests on four pillars. First, a trusted, independent, and accountable health authority. Completing the governance reform Member States have began, and defining WHO’s distinctive place in a fragmented global health architecture, following the clear mandate spelled out in the Constitution. Second, financing the independence WHO needs, pursuing the agreed increase in assessed contribution to half of the base budget by 2031, with support for countries in fragile situations, and in return, a leaner organization that is willing to say what it will stop doing. Third, delivering the unfinished business in countries.
Primary health care is the road to universal health coverage, and it depends on health workers who are trained, retained, and ethically recruited. Non-communicable diseases and mental health must be prevented through a proactive health in all policies approach. Women’s health across the whole life course, as well as children’s health, will be a personal priority to me. Polio eradication must be completed, as well as the elimination and control of neglected tropical diseases. The amended international health regulations and the pandemic agreement should be implemented in full.
Fourth, preparing for what is coming, so that new medicine, genomics, artificial intelligence, and digital health reach lower income countries on the same timeline as wealthy ones. And so that health is central to the response to climate change. The health sector itself produces around 5% of global greenhouse gas emissions. I will support countries to build low-carbon, climate resilient health systems, and WHO will reduce its own emissions, leading by example. Dear colleagues, I have spent 30 years close to patients and to the people who care for them.
For 17 years, I led Hamad Medical Corporation, Qatar’s largest and main public health provider, developed it, strengthened its resilience, and promoted a primary health care approach, while at the same time pursuing its transformation into an integrated academic health system. For close to nine years, I served as Minister of Public Health. I designed and delivered two national health strategies and led my country’s whole-of-government response to COVID-19. I know what a strong health system means for a community, and I know what happens when systems fail those who need them most. I have also sat on the other side of the table.
I chaired WHO’s executive board, including the special session on humanitarian access to RESE. I chaired the regional committee for the Eastern European Mediterranean and served as vice-chair of the Bureau negotiating the annex to the pandemic agreement on pathogen access and benefit sharing. That experience left me with one conviction. WHO is strongest when every member state knows that it has been heard. That is why I began by listening.
Between August and October 2026, I met around 130 Member States at all six regional committees at Addis Ababa, Delhi, Washington, Cairo, Manila and Copenhagen. Their messages were consistent. They want guidance concise and clear enough for ministers and frontline staff to use; spending they can see and justify to their parliaments and people; a WHO that is present in their countries and listens to their needs; a fair policy for health workers’ recruitment, retention and development; a voice at the design stage of decisions; Small and island states asked to be treated as a constituency in their own right. I will take full account of these comments and suggestions. My leadership will rest on a few clear principles.
Science and evidence first, which are insulated from undue influence and candid about uncertainty. Delegation with accountability within a unified senior team. Decisions taken closer to countries. Informed by an independent review across all three levels of the organization. An investment in WHO’s own people.
And regular consultation with the executive board, regions, partners and civil society. Ladies and gentlemen, the election of a director general is not the decision of an administrator. It is a choice of a direction. I will listen. I will build consensus.
And where decisions must be made, I will make them an answer for them. I am ready to take this direction with you. And I ask Member States to lead with me. Thank you very much.
CHAIR: Thank you. We will now continue with the questions and answers. I shall now invite Member States and associate members wishing to ask the candidate a question to place their blue token in the receptacles corresponding to their region. May I please ask Secretary to collect the tokens and to display the relevant token on screen. I shall now pull one token from each of the receptacles following the order of the regions previously determined, starting therefore from the African region.
Once the six tokens, one per region, have been pulled out, I will invite the corresponding Member States or associate members to ask a question. Vielen Dank. Kiitos. The six members that will be given the floor to ask questions in the first round are Kenya, Egypt Barbados Italy Indonesia and Thailand I shall give the floor to Kenya to ask questions. The 50-minute period will begin simultaneously with the activation of lighting system.
KENYA: Thank you, Chair. Good morning, Delegates. Dr Hanan, welcome. Our question is direct. Prequalification opens the door for African manufacturers, but sustained orders are what keeps them in business.
What would WHO do under your leadership through pooled procurement and demand guarantees to make regional manufacturing commercially viable? Thank you.
CHAIR: Dr Hanan Mohammed Al-Kuwari, you have the floor.
DR HANAN MOHAMMED AL-KUWARI: Thank you very much. Thank you, Kenya, for this question. Indeed, we have all learned from the COVID pandemic the importance of regional manufacturing. And the African region has done great strides, especially with the Accra Reset and the commitment to local manufacturing. And I strongly believe that for us to be able to better address future pandemics, regional manufacturing is essential.
And as you said, pre-qualification is necessary and WHO will continue to support Member States in pre-qualifications as well as standard setting. We also need to ensure that we work in partnerships with public and private partnerships to ensure that we are able to establish manufacturing capacities necessary per region. And also we need to ensure that there is the critical mass of work necessary in between pandemics to ensure that the regional manufacturers function appropriately and are able to respond in crisis. So for me, I would support and encourage the continuing work that has been started at WHO around preparing for manufacturing, regional manufacturing. I would also support and encourage the work that the African region has done and that’s really wonderful progress.
I would also work in close partnership via the process for engaging with non-state actors to ensure that the private sector is able to also to respond to this need. But I would here also like to emphasize that we need to complete the work we have started with the pandemic agreement to allow us to do that well. And we need to continue the pandemic negotiation process, the annex to ensure that we can do that well. Thank you.
CHAIR: Thank you. I shall give the floor to Egypt.
EGYPT: Dr Hanan. Dr Hanan, good morning and I wish you good luck. Your pastoral as the vice chair of the Bureau of Intergovernmental Working Group on WHA Pandemic Agreement and your tireless efforts at the EMR region, leadership, your excellency leadership the chair of the EMR Regional Subcommittee for Polio Eradication and your overarching leading mini-regional efforts on fight both communicable and non-communicable diseases. Our question will be on the financial constraints that faces the organization right now if Your Excellency would expand more in your efforts in this regard. Thank you so much.
DR HANAN MOHAMMED AL-KUWARI: Shukran, Egypt. Thank you very much for this question. Yes indeed, as I mentioned, it is really important that we continue to support WHO’s financial independence because an independent WHO, a financially independent WHO, belongs to all Member States and can always stick to the sciences and the facts. And for that I thank Member States for their commitment to increasing the assessed contribution. That’s really important to continue that effort.
And I’m proposing a system to support fragile Member States that cannot do that, a pooling system. I also will encourage Member States that are donating and are very generous donators to focus on non-earmarked donation rather than earmarked donation, because when it’s non-earmarked, it contributes to the priorities that we set as Member States through the general program of work. Also, I would ensure that we activate the WHO Foundation. So we have established a foundation, a WHO Foundation, which has started collecting donations, but is not yet working to its full capacity and its full potential. So I would work with the WHO Foundation to ensure that the standards that they follow are ethical, transparent, that Member States can trust the foundation and that we can start receiving donations through the foundation as well.
But also I would focus on dedicating teams that would look at financial donations and contributions because right now employees within WHO are also focusing a bit too much on collecting donations and I would like the department heads, project leads, directors not to worry about the financial situation and to leave that to a team of experts who would be doing the collection, the donation on their behalf so that their focus and energy is on their programs of work. Thank you very much.
CHAIR: I shall now give the floor to Barbados to ask questions.
BARBADOS: Thank you, Chair. Small Island Developing States face disproportionate health vulnerabilities. If elected Director-General, what concrete measures would you introduce to ensure that WHO’s technical assistance, financing mechanisms and resource allocation frameworks adequately respond to the unique vulnerabilities of SIDS, including countries classified as middle or high income? Thank you.
DR HANAN MOHAMMED AL-KUWARI: Thank you very much Barbados. I must say that I have an affinity towards supporting small states and small state islands. Because myself, I originally started as a small state and we graduated as Qatar. So when I started working in the health system, we were considered a small state. But over the years our population grew and we became sort of a middle state.
Graduated from that status. So I know very well the challenges of small states and I would ensure I would ensure to work very closely with small states to develop solutions that are practical and That make a big difference. So I know that there’s limitations on Ability to receive technical assistance. I know there is challenges of climate related climate resilience and the challenges of climate. I also know that recruitment is very difficult.
I know that there is shortage of workforce in small states. So I would propose a forum for small states to come together and develop a specific program for small states. Thank you.
CHAIR: I shall
ITALY: The WHO ILO joint estimates attribute almost 1.9 million deaths in 2016 to work-related diseases and injuries, showing that work is a major determinant of health and health inequalities. Yet WHO’s work on workers’ health has been progressively weakened over the years and further reduced in the 2025 prioritization. While ILO leads on labor standards, the health dimension of work is WHO’s own responsibility. If elected, what concrete steps would you take also in consideration that the last global plan of action on workers’ health expired in 2017?
DR HANAN MOHAMMED AL-KUWARI: Thank You Italy. Yes, workers’ health is really important and that’s one area that I also focused on in my career. So in the national health strategy in Qatar I I put workers’ health as a priority and one of the targets I had was that 70% of all employers would have a workers’ health program and that the ministry would check on the workers’ health program and ensure that it’s in place. So for me, workers’ health is a priority and I would ensure that it remains a strong program and is developed. It is also a great opportunity for prevention.
And to me, prevention is really important as we move forward, ensuring that we have early access to preventative services, to care, to lifestyle, nutrition, all of those elements, workplace health is a wonderful opportunity for that, as well as school health programs. So I will be looking at all potential opportunities where we have a population that we can reach to, such as through workers’ health, to ensure that we maximize that opportunity and ensure that they have a wellness program in their workforce, in the organization, as well as access to primary health care and services when they need that, as well as occupational safety. So all the different elements of occupational and workforce health. Because also, as health care providers, we need occupational health to ensure that our health workers are safe and protected at all times, and that’s a very important priority to me as I am really passionate about patient safety and staff safety and quality. So ensuring that our staff, wherever they are in the health systems, have the right protection and access to health services and preventative services as well as the general community.
Thank you.
CHAIR: I shall now give the floor to Indonesia to ask questions.
INDONESIA: Thank you, Chair. Dr Hanan, Indonesia is revitalizing primary health care for more than 280 million people. For countries pursuing reform at this scale, the challenge is less about knowing what works and more about delivering it across diverse settings with sustainable financing and the right health workforce. Your CV shows relevant experience where you promote a health in all policies approach. We note your vision to make primary health care the route to universal health coverage.
Our question is, as Director-General, how would you use primary health care to help countries accelerate progress towards universal health care coverage at scale? Thank you.
DR HANAN MOHAMMED AL-KUWARI: Shukran. Thank you, Indonesia. Yes, indeed for me primary healthcare is the most important platform that we can use to address many diseases and reach many targets at the same time. So I would invest a lot of energy in ensuring that primary health care is available to everyone everywhere. And I will work closely with Member States to ensure to understand the challenges and limitations in order to ensure that not only do they have the right scope in primary health care, they have universal health coverage, they also have the financial assistance that they may need in order to develop fully their primary health care network.
In Qatar, I was responsible for primary health care, so I ensured that we had a network of primary health care services across the country. And that platform is extremely important because not only is primary health care important in terms of routine prevention, immunization, but it’s also really important for resilience and preparedness for emergencies. In Qatar, when we had the pandemic, we used primary health care for testing, for vaccination, And it was having that network of primary health care available and accessible immediately that allowed us to be more resilient. So for me, primary health care is not only about prevention. It’s also about resilience and ensuring that you have full coverage of your population.
And in terms of scaling primary health care, indeed, it’s really important. I had that experience when I started. We had a few primary health centers across the country because our population was smaller in size. And as the population grew very rapidly, I more than doubled the primary health centers rapidly, and I will be able to work with Member States to understand how they can scale up their primary health care networks across the region. And I am committed to primary health care.
I would like that to be one of my flagships should I be elected, and will ensure that I work with all Member States towards that. Thank you.
CHAIR: I shall now give the floor to Thailand to ask questions.
THAILAND: Thank you, Chair. Dr Hanan, many middle-income countries face a rising burden of population ageing and non-communicable diseases, yet they are increasingly eligible for concessional international financing. Under your leadership, how would WHO adapt its approach so that these countries receive the technical support and access to financing they need? Thank you.
DR HANAN MOHAMMED AL-KUWARI: Thank you very much. Indeed, the rise of non-communicable diseases and the attention we need to place on non-communicable diseases is important. Needs to be at the top of WHO’s agenda. And the ageing population across the developing world and the developed world is putting more pressure on us to ensure that we are able to address non-communicable diseases. And the best route to address non-communicable diseases is through primary health care and ensuring appropriate secondary prevention is available to Member States.
And I heard also from Member States that there are significant challenges in some areas to develop the specialized services that are needed for preventative services. So not only do we need to ensure we have the right primary health care platform, but we need to ensure that we have the right secondary care platform to be able to receive the patients that are screened in primary health care. So it’s important to develop both primary health care and early secondary prevention. And in terms of financial or international financial assistance, WHO’s role is to support Member States to seek and find the appropriate funds for international financial assistance. WHO itself does not finance Member States but WHO in my opinion is committed to the outcome and impact of our programs.
So whenever we set a target or a plan, we will be assessed based on results, and that means that Member States need to implement our recommendations. And if Member States do not have the financial means to do that, WHO needs to help Member States reach the right funds, because there are multiple international funds available, and WHO needs to support Member States to reach the right fund that will help support in that target. So we do not directly contribute to the financial assistance, but our role is to support and guide and ensure that Member States can implement our recommendations and therefore reach the right financial assistance they may need. Thank you.
CHAIR: I found that the first six questions and answers are read out and given. I would also like to remind the Member States not to ask the question for other Member States in this. We have already said that ask according to the color coding. So if you have asked for other candidates, the question will be ignored. The lighting system tracking the 50-minute period will now be paused.
Further questions and answers. I shall now ask the Secretary to merge the contents of the six receptacles into one and will continue with the selection of Member States or associate members until the time available is exhausted. Each time a question is posed and answer is provided, the lighting system will be activated to track the one-minute period for the question and the three-minute period for the response, respectively. So, I also request the Secretary to fold the questions because it’s very difficult to take the unfolded questions. Thank you.
We will wait for a while for the timer to be sorted out. Thank you. Please sort out the timer properly and then pause it. The question and answer session should be zero and then the total time should be the last pause time. I think it was 33.03 the total time.
Pause, pause, 33-03. Question answer set to zero. Q&A. That will happen. Okay.
So, now I’ll have to pick. I shall now give the floor to Japan to ask a question. The lighting system tracking the 50 minute period for the question and answer session will be reactivated at the same time.
JAPAN: Thank you, Chair. My question is about global health architecture reform. While various global health actors, including global health initiatives, multilateral development banks, and UN agencies have made important contributions, to improving health outcomes. Fragmentation and duplication remain as significant challenges. Given the ongoing WHO-led process on global health architecture reform, what role do you believe the WHO should play in strengthening and shaping the future global health architecture?
Thank you.
CHAIR: Dr Hanan Mohammed Al-Kuwari, you have the floor.
DR HANAN MOHAMMED AL-KUWARI: Thank you, Japan, for this question. Indeed, we have reached the positive outcomes that we have today because of the global health architecture that we have today. So every member of the architecture is really important. And we have seen the document that was produced by the African Member States, the ACRA Reset document, and that’s a very good document. That I subscribe to it and I think it’s the right direction.
The details of that is up to Member States to implement and the governance of each country and program to implement. In terms of the WHO process as well, we have a process that we started, the task force for the global health architecture and I also believe that’s in good hands the Member States and the engagement level in Member States is very good so I’m looking forward to seeing the reports and outcome of that document and I will implement that document with Member States in terms of WHO’s role WHO’s role to be is extremely important and I think we can step up to do much more of our coordinating and steward role than we are doing today and that’s because we’re doing so much more than we should do. So for me, that’s why I go back to the functional review that I mentioned in my presentation, that there is an opportunity for us to look at what we’re doing, how we’re doing it, and can we do this more efficiently and can we be more lean as an organization. And when I look at the functional review, I see that it needs to be done with a few concepts in my principles. One of it is partnership.
So whatever we can rely on other partners to deliver, whether it’s regional structures, whether it’s non-state act, I mean, non-profit organizations, part of the UN family, we should do that so that we can focus on our core mandate of setting norms and standards and convening. But that said, we need to do it well and we need to ensure that they’re held accountable for the pieces that we ask them to do. And so for me that’s important because we are responsible for things, but we don’t need to do things ourselves So it’s ensuring that other pieces that we delegate to others are done correctly and are done according to a contractual relationship with them And I use contractual and abstract for them. Thank you
CHAIR: I shall now give the floor to New Zealand to ask questions.
NEW ZEALAND: Thank you, Chair. Given the diversity of needs across Member States and WHO’s constrained financial resources How would you balance addressing the unique needs of SIDS that you have already identified with WHO’s broader global health priorities?
DR HANAN MOHAMMED AL-KUWARI: Thank you Thank you very much. So I understand the questions on the constraint resources on WHO itself, right? Yeah, so yes, I think as I just mentioned earlier it’s we need to continue to work in partnership that’s important but we also need to increase the assessed contributions we need to increase our non earmarked donation and we need to fully function the WHO foundation so to me these are three important pieces that we need to continue to pursue so the WHO is fully funded and also at the same time Member States have a lot of pressure on their funding their resources so we need to make sure that they know that WHO is an organization that is lean and that is fit for the future that’s fit for purpose so that they can continue to donate to WHO because if they do not feel that we are responsive and we are accountable and that we are focusing on our results and have the impact that that they would like their donation to make, then they are not encouraged to donate. So for me, it’s encouraging the donations into WHO non-earmark donations, but also responding to Member States in terms of the reforms necessary, the accountability that is necessary, and showing the impact and results of our work. Thank you.
CHAIR: I shall give now the floor to Bangladesh to ask questions.
BANGLADESH: Thank you. Madam candidate, our question is: you are pleased to fully implement the WHO pandemic treaty. How would you ensure that low-income countries develop indigenous scientific and technical capacity drawing on global science and innovation?
DR HANAN MOHAMMED AL-KUWARI: Thank you very much. Yes indeed the pandemic treaty has a number of components that need to be activated in order for the benefits of the pandemic agreement to be realized. So for me it’s really essential we need to continue that piece of work and encourage the PABS annex to complete. And I’m very motivated by the re-energization of the Bureau and I look forward to in May completing that piece of work. And I hope and I’m motivated that they will complete that piece of work.
We will complete that piece of work. And because it is essential to put together the financial mechanisms for the pandemic agreement and the PABS negotiation piece will define also the science and the exchange of pathogens and the development. And if you saw very clearly in the negotiations, the importance of knowledge transfer, of training and development of developing the manufacturing capacities and the scientific institutions and the academic institutions in the developing world is essential piece to the pandemic agreement. So I will pursue the pandemic agreement. It is addressed in the pandemic agreement and I will ensure it’s realized to its full potential.
But in principle, in general, I strongly believe that it is important to develop the scientific capacity in all Member States. I myself developed the scientific capacity in my country, so I established the Biobank, the Genome Project, the Precision Medicine Institute in Qatar, and I strongly believe that you need the strong scientific and academic platforms in order to then develop your local manufacture and your local industry. So it’s really important, that piece is important, and WHO has a role to support Member States in developing their skills, and there it’s important to encourage exchange of knowledge and solidarity between Member States and partnership with the private sector as well. Thank you.
CHAIR: I shall now give the floor to Bahamas to ask questions.
BAHAMAS: Thank you, Chair. Climate change is increasingly affecting health outcomes in the Caribbean through extreme weather events, vector-borne diseases, food insecurity, and mental health impacts. How would you position WHO to better support Caribbean states in the intersection of climate and health, and what new resources would you seek to mobilize? Thank you.
DR HANAN MOHAMMED AL-KUWARI: Thank you very much. This is an important question. I was really touched by this when I was speaking to ministers of health from the Caribbean islands and the small states’ islands. Because I looked at it and when hearing the plight and the challenges, it reminds me how in our region we have wars and conflicts. So you build your health system and then through war and conflict it’s destroyed and then you have to rebuild it again.
And that is a toll on the population, it’s a toll on the health workers, it’s a toll on the economy and it has a lot of consequences. And when I heard the plight of small Caribbean islands that build their health systems and then a flood, a hurricane comes and destroys it all and they have to build it again. And the next season this is destroyed again due to climate change. Then I really feel for it because I know what that feeling is. So for me, I’m committed to doing something around supporting Member States for climate resilience and ensuring that health systems are ready to address climate change.
So I saw Member States have adaptation plans, but less than half of the Member States have climate resilience adaptation plans. So that’s important to pick that up and do it. As well as for those who are hardest hit and most affected by climate change, I would support a special fund for that. Working with, of course, development banks and the World Bank, because it’s not WHO can do that. And as well as I would support in ensuring that they can access funding through the development banks that today have access have funds allocated to climate change.
So to me that’s really essential and important and I will continue to pursue support for a small island states for climate change. Thank you.
CHAIR: I’ll give the floor to Germany to ask questions.
GERMANY: Thank you very much, we were waiting for that. So we haven’t touched upon internal structures so far, and we would be very much interested in learning more about this. The assembly will elect not an individual but a leader. So we would like to know more about your leadership team, how you would select it, what kind of characteristics you would want to have and what kind of leadership style you would perform. There are different styles, micromanaging, taking decision, leading by example, delegating authority and we’d like to know more about your style.
Thank you very much.
DR HANAN MOHAMMED AL-KUWARI: Thank you very much for this good question. Indeed, a leader is only as good as his team and the team that surrounds them, and is only as good as the governance. And that’s why I say it’s about membership, governance and leadership. I would really welcome representation. So for me that’s important.
The more we can have Member States represented in the organization, at headquarter, regional and country level, as well as in my top leadership team, I would welcome that. But I have one request, I would like the best. So please send me your best and encourage your best to apply to WHO to the different roles because we are only as good as our talent in this organization. We are a health authority that provides knowledge, guidance to Member States. So it’s about the quality of our workforce number one.
And for me I will look forward to having a strong management team and leadership team with me. I will delegate authority to them. I will not micromanage. I believe that we need to be all aligned to the plans, the goals that we have and all the team as well as the organization needs to be aligned to that goal and work as one. So to me that’s the principle.
We need to all work as one and I will hold them accountable also. I will ensure that we have a safe, collaborative, a harmonious culture in the organization. I strongly believe in a strong organizational culture for change. You cannot achieve change without a strong culture in your organization and I think that that is essential. I have implemented many change programs and if you don’t have your leadership and your workforce all aligned and all committed, it will not happen.
So to me that that that is an important element and I will hold everyone accountable to resorts like I hold myself accountable to the results. Thank you.
CHAIR: I will give the floor to Denmark to ask questions.
DENMARK: Thank you very much, Chair. Our question is: How do you see the WHO’s normative role at the global level, including its role in applying new scientific evidence and setting global standards and guidance? And how will you ensure that the WHO has the capacity to safeguard these functions? Thank you.
DR HANAN MOHAMMED AL-KUWARI: Thank you very much. I think that is the most important goal that we have, which is setting the right quality of normative guidelines and goals. And when I was motivated to run for candidate, it was the memory of how strong WHO’s guidelines are to me, both when I was studying as well as early in my career. So you all look up to WHO as the gold standard of guidance, of norms, and that still remains very much so, but it’s shaken. So I would like to make sure that we are the gold standard of norms and standards.
My colleagues all in the health system, whenever there is a decision or a conflict or a question mark on what we should do, all look up to WHO guidelines and they all look up to the norms that WHO recommends. So to me that is essential. We need to protect that, ensure that our guidance are strong. And for our guidance to be strong, we need to have the strongest working groups, the strongest technical teams that are reviewing our guidelines and developing our guidelines. And here again, representation, quality of our scientists that contribute to the guidelines that we will establish is important.
And ensuring that the guidelines are developed under the sort of a scientific rigor. So to me, I will invest a lot of energy on ensuring that we have the right norms and guidelines and that we develop that within the right process. And that process needs to be transparent because Member States need to understand why our guidance and our recommendations as such. Because during COVID, that was not so clear and that was not so transparent. And that’s how we lost a little bit of the trust from Member States and from the general public.
So we need to be very clear on our role. We need to be very clear on our guidelines. And we need to be very clear on how we do things. Thank you.
CHAIR: I shall now give the floor to Finland to ask questions.
FINLAND: Thank you very much Chair Dr Al-Kuwari. Our question would be how would you ensure that funding decisions are better aligned with strategic priorities and long-term planning rather than donor preferences?
DR HANAN MOHAMMED AL-KUWARI: Thank you Finland for this good question indeed. By ensuring that the donations are non-earmarked, we ensure that they go towards the priorities that Member States agreed upon. So my intention for example now even with this document, with the vision document I have, it’s very much of an envelope. I will be further shaping this over the next few months and post the shortlisting. And then that will feed into the general program of work, which Member States will agree upon.
And once that is agreed upon, that’s where the non-earmark donations will pour into the general program of work. So the way I see it, everything needs to roll into the general program of work. Because that’s the direction that Member States have put together, and that was a process that we, as Member States, went through the rigor, the targets, the study, to ensure that these are our targets. So once the Member States have agreed on the general program of work, and we have one now that is halfway or close to ending, I would ensure that the donations pour into the targets agreed upon in the general program of work, to ensure that there’s a fair distribution of the donations and the contributions. And I would continue to pursue the non-Earmark donations as much as possible.
So that’s how I would ensure that that goes towards the goals agreed by Member States rather than donors. Thank you.
CHAIR: I shall give the floor to Lebanon to ask questions.
LEBANON: Thank you, Mr Chair, and thank you, Dr., for your presentation. You mentioned that one of your aims is to unite the world around health, but the world is not united, and many conflicts are impacting many countries around the world. So if elected, what would be your vision to strengthen the protection of medical services, medical institutions, and first responders? And I thank you.
DR HANAN MOHAMMED AL-KUWARI: Thank you very much, Your Excellency, for this question. Indeed, I think the world needs WHO today more than ever. And our role in terms of setting guidelines, convening in difficult circumstances such as war and conflict is really important. And ensuring continuity of services and access to services in war and conflict is essential. And that’s why I will continue to speak strongly around protecting access to healthcare during wars and conflict and protecting health facilities and access to humanitarian services in war and conflict.
And I will also support that we continue to support humanitarian activities, but we do that in strong partnership with our humanitarian partners. WHO’s role is the coordinator of humanitarian work in conflict settings, and WHO’s role is also ensuring that there is resilience in health systems. So through resilience programs to ensure that there is access to medicine, there is the essential stockpiling, essential medicine available during wars and conflict, and ensuring that the regions play a strong role in technical support and in humanitarian support and coordination of a conflict in zones of conflict. Thank you.
CHAIR: I shall give the floor to Pakistan to ask questions.
PAKISTAN: Thank you very much, Dr Al-Kuwari. You led a national COVID response as minister, quite inspirational that was, which helped steer the – and it later steer the pandemic agreement negotiations as well. So for many developing countries, equity remains the test of that agreement. So as DG, how would you ensure that access to countermeasures, technology transfer, and benefit sharing are actually delivered to the developing countries? Thank you very much.
DR HANAN MOHAMMED AL-KUWARI: Thank you very much. And indeed, the COVID pandemic has shown us that health systems resilience and strength is important that essential medicine and essential stockpiles are important. And that when health systems are unable to respond to demands and search demands and capacity demands, the whole society is blocked. And to me, access to medicine, supplies is essential and it’s important that we work with the private sector that it is priced reasonably accessible to lower and middle income countries across all regions fairly and equally. I also believe strongly that in order to ensure that we have appropriate access to medicine and stockpiles, It’s important to develop the right partnerships to find the right financial mechanism and tools and the pandemic agreement is one of those mechanisms and tools.
The World Bank, the development banks also have mechanisms and pools that Member States can reach to. But more important is develop the capacity of your own health system and your own infrastructure. Health systems and the health ecosystem altogether in Member States need to function to their full. So whether it is the regulatory elements in Member States, whether it’s the regulations that they need in place, WHO helps with establishing the regulatory infrastructure, the regulatory framework, the pre-qualifications necessary for access to medicine, whether it’s supporting the manufacturing industry to ensure that they have local productions, whether it’s local manufacturing in regions. So all these pieces need to come together so that in conflicts, in crisis like COVID, the health systems are resilient and able to respond.
So for me, it’s bringing back to resilience and all the pieces of resilience are essential in the health system.
CHAIR: I shall give the floor to Nepal to ask questions.
NEPAL: Thank you, Chair. Madam Candidate, this question relates to the international recruitment of health personnel. Countries of origin, particularly developing countries, bear the cost of educating and training health personnel that often ludes them to international. This can deepen workforce shortage and undermine access to essential health services. If you elected director general, how would you ensure that destination countries co-invest in the education, training and retention of health personnel in countries of origin?
Thank you.
DR HANAN MOHAMMED AL-KUWARI: Thank you. The health workforce question is really important and indeed we have a global shortage of workforce. And I heard it from Member States that are losing health workers to others, that this is starting to put pressure on their health systems. And it’s important, therefore, as you said, to co-invest. There are mechanisms in WHO that are in place.
So support through education, support with also ensuring that there is no recruited from the countries that are protected and considered that there should be no recruitment from them. There are about 50 countries that WHO identified should be protected from recruitment from. So for me it is important that we recruit ethically and therefore it’s important to ensure that there is a program to educate health workers from the countries that are exporting more of the health workforce. It’s not, it is difficult to put a halt to movement of workforce, but it is important to make sure it’s fair. And it’s fair to the country that is training and developing the workforce.
And it is also fair for the individual that’s moving and migrating. So for me, the fairness of this process is essential. And there is recommendations already in place in WHO. I will look at them further with the Member States that are the highest to contribute to the global workforce And ensure that that’s available and also ensuring that there’s a right training and development Everywhere across the world to reduce that so we have a wonderful WHO Academy that’s able to work At helping supporting training and development of workforce so that also Member States do not need to recruit as money from the countries because that was especially important in small states where challenges of recruitment are our biggest. Thank you.
CHAIR: I shall give the floor to Iceland to ask the last question.
ICELAND: Thank you.
DR HANAN MOHAMMED AL-KUWARI: Thank you very much. Well the answer to this one is very simple: science and evidence first. That is the most important recommendations that WHO has to give and that’s the position of WHO. That would be my position as well. And in terms of reproductive health and maternal health that to me is a very important agenda.
I myself, my first leadership role was the director of the women and children’s hospital so I was responsible for the welfare and the well-being of women in my country and that’s why I put that as a responsibility as a priority for me in WHO so maternal mortality was a target for me which I managed to drop to four out of four out of hundred thousand per population and so there is a for me woman’s health reproductive health sexual reproductive health are really important and to me also the element of human rights, non-discrimination, access to healthcare services is essential. WHO’s guidelines and norms need to always stick to the science element and to the human rights element and Member States will then take our recommendations and implement it in their country as their laws and their regulations see fit. But our position will always be the science and protection of the rights of everybody, regardless of race, nationality, gender, whatever, to health services, because that is really important for us as an organization. And as I said, women in health is an important priority to me personally. Thank you.
CHAIR: Sorry, since we have time, we still have one more question. So, I shall give the floor to India to ask questions.
INDIA: Thank you, Chair. We have a question that follows. Countries with very large diverse populations generate some of the world’s most valuable health data. There is real concern that global rules on AI and health will be written by a handful of countries and technology companies. How would you ensure that countries contributing to this data have a genuine say in setting the rules and that data generated from their patients ultimately benefits those patients rather than only training commercial models elsewhere?
How would you make sure the Global South helps write these rules rather than simply inheriting them?
DR HANAN MOHAMMED AL-KUWARI: Thank you very much. Indeed, I’m glad the last question is on the future, which is AI and health. That’s important. We need to position ourselves correctly for the future. And for AI tools, as you mentioned, it’s important that they are developed with differences of populations in mind.
And therefore the more they are inclusive, the better. And, but at the same time, we need to develop the guidelines as necessary to support Member States, to ensure that their data is protected, their data sovereignty is protected, their patient confidentiality is protected. ‘Cause these are the guidelines that we are doing. And I think that I’ve seen some of that work already place in WHO, some from the European region, there’s good efforts to ensure that the AI guidelines and document and rules or guidelines, AI guidelines are strong and they are ethical. And we need to continue that piece of work. And since we speak of AI, I hope that also in WHO we will ourselves modernize ourselves and so that we can have even an easier process than the times that we have today and the mechanism that we have today for voting.
And so I look forward to really implementation of AI within WHO, but within Member States, however, within an ethical framework and with the right guidelines, because that is the future coming forward. The way health care is delivered will change significantly in the future, and I would like WHO to be much more proactive and have much more foresight and planning with Member States for that future state, because we will be delivering healthcare very differently in the next two decades, whether it’s AI or other technologies that are essential in improving the way we deliver care, the way we have helping us with better access to care, but also ensuring that our workforce also is protected in this process. So AI, modern technology, modernization, that’s a very good end note to the last question, I believe, Your Excellency. Thank you.
CHAIR: The time allowed for the questions and answers is now exhausted and so is the total time allotted for the interview. I wish to thank you Dr Hanan Mohammed Al-Kuwari for being with us today and I would like to I would ask the Secretary to accompany you out of the room. While the Secretary is accompanying Dr Hanan Mohammed Al-Kuwari out of the room and Dr Hans Henri P. Kluge is being brought in, I would like to ask the delegations to remain in their seats so that we may begin the next interview as soon as the next candidate is here. Thank you.
Thank you. Good morning, Dr Hans Henri P. Kluge. Welcome to the First Candidates Forum for the election of Director-General. I wish to thank you for coming to this interview today.
I understand that the Secretary has already informed you of the way we shall proceed this morning, and I propose that we start immediately with your oral presentation. You have the floor.
Interview of Dr Hans Henri P. Kluge
DR HANS HENRI P. KLUGE: Mr Chair, Excellencies, colleagues, Bonjour, buenos días, dobroye utro, [unclear], assalamu alaikum, habari zenu, Good Morning to you all. I stand before you as a medical doctor. My real education happened in four WHO regions, in Somalia and Liberia during the civil wars with Médecins Sans Frontières, two years in the prisons in Siberia fighting tuberculosis, five years in Myanmar with missions to Thailand and DPRK. And the first thing a doctor learns is simple: listen before you prescribe. So my manifesto, you see here, is called Rebuilding WHO Together.
In one sentence: a WHO which is trusted for its science, useful for every country and owned by you. But it is only a living document. It’s a draft prescription because WHO is your organization. Thanks to the formidable support of the Belgian government, I’m in the midst of a global listening tour. Six region committees, 15 executive board countries, 19 to go, listening to ministers, patients, health workers, young people, civil society.
And so far I heard three messages. Remember a doctor’s habit. Keep the diagnosis short. First message. The world wants its WHO back.
Science above politics. Member States want WHO to be what it was built to be. Technical, rigorous, neutral. Second, results above free organization. People are tired of reform that do not reach the clinic.
They want to see results in the district, not in the organigram. And third, universality. A WHO with empty chairs is a weaker WHO for all of us. The door must remain open and the next director general has to work patiently to bring back those who left. The world wants its WHO back.
Message number two. One WHO, six regional realities. A strong WHO stands on strong regions. Geneva sets the norms, the regions bring them to life. In Africa and the Eastern Mediterranean, I heard one word.
Souverainty. The Accra Reset is not a slogan. It’s a reality. Local manufacturing, pooled procurement, technology transfer. [In Dutch] En ik ontmoette health workers die naar het werk gaan, die niet weten wanneer ze naar huis komen.
[Editor’s translation: And I met health workers who go to work not knowing when they will come home.] Attacks on healthcare should never become the new normal. [In Dutch] In de Amerika’s en de West-Pacific [Editor’s translation: In the Americas and the Western Pacific], I heard respect. PAHO is older than WHO itself. Its autonomy is a strength. And the small countries were telling me that they are living on the front line of climate change today, not tomorrow.
In South-East Asia and the European Region, it’s about the health workforce. One question from Asia stays with me: why does a health worker decide for the city even when a rural health post pays twice as much? Because salary is not everything. Training, safety, a school for the children matter. One WHO, six realities.
And the third message was maybe the loudest. I heard it in every region. The countries want a new way of working with WHO. They want WHO inside the country, [in Dutch] niet naast het land, de beslissingen dicht bij waar de mensen leven. De landen willen één plan, hun nationale plan, met WHO, Global Fund en Gavi en alle partners erachter.
Eén plan, één rapport, één budget. En de landen willen zichzelf herkennen in de context. [Editor’s translation, partly uncertain: not next to the country, with decisions close to where people live. Countries want one plan, their national plan, with WHO, the Global Fund, Gavi and all partners aligned behind it. One plan, one report, one budget.
And countries want to recognize themselves in the context.] A low-income country, a fragile state, a middle-income country, a small island, they all have different starting points. Countries want a new way of working with WHO. So, what is the draft prescription after a preliminary diagnosis? Four commitments. Number one, country first with strong science.
More staff and resources in the countries. Lean headquarters. No duplication across the three levels. And a firewall around science. Norms and guidelines that no donor and no superpower can bend.
If I’m elected DG in the first months, I would establish an independent expert group on financing and a Member State-led process on stop doing things. As we say in German, Ordnung im Haus, Wirkung im Land. Order in the house, impact in the country. Message number two, the last will be the first. Low income countries, predictable support and local production, so access no longer depends on geography.
Fragile states, WHO first in and last out, and the head of state coalition to finally stop these terrible attacks on healthcare workers. Small islands, a special envoy from day one and more islanders in WHO. Third commitment, strong regions and strong regional institutions. The African Center of Disease Control, the African Medicines Agency, PAHO, the regional economic communities. They are our partners, not our competitors.
My vision of a network WHO means that every country in the world will be a champion in one area to share with other countries through strengthened inter-regional collaboration. And finally, fourth commitment, my signature initiative on primary healthcare. Not as one more program, but as the corporate integrated delivery platform for everything else. Universal health coverage, preparedness, mental health, aging, climate change. Thailand, for one, has shown what’s possible with political commitment and social participation.
Khob khun krab. And valued health workers with artificial intelligence and digital health serving the health workers, not replacing them. In 2028, we’re going to mark 50 years of the Alma-Ata declaration on primary health care. Alma-Ata promised health for all. Fifty years on, I would like primary healthcare seen be judged by a performance dashboard.
Let me end where I began, at a patient’s bedside. In 1995, I was a young MSF doctor in the children’s ward in Kismayo Hospital in Somalia. We had almost nothing. But what kept us going were the Somali doctors and nurses who refused to forget that word. That is what WHO stands for.
I do not want to celebrate Alma-Ata with nostalgia. I want to celebrate Alma-Ata with delivery. A WHO like a tree. Deep roots in every community. Strong branches in all regions, and one trunk of trusted science.
Rebuilding WHO together, my friends, is not about institutions. It’s about the mother who survives a complicated childbirth. It’s about the girl who reaches her fifth anniversary. It’s about the health worker who comes home to the family alive. So my request this morning is straightforward.
Let us rebuild WHO together. Merci beaucoup. Gracias. Spasibo. Xièxie.
Shukran. Asante sana. Thank you.
CHAIR: Thank you. [Beginning of statement not captured.] […] tokens and to display the relevant tokens on screen. Please fold if it is not folded. I shall now pull one token from each of the recipient receptacle following the order of the regions previously determined starting therefore from eastern Mediterranean region one once the six tokens one per region have been pulled out I will invite the corresponding Member States or associate members to ask question Vielen Dank. Thank you.
I shall now give the floor to Lebanon to ask questions.
LEBANON: Thank you, thank you, Mr Chair. The question of Lebanon is going to be about NCDs, which remain a major public health challenge, particularly in EMRO, and in countries where economic constraints and recurrent emergencies disrupt access to essential health care. So what concrete measures would you prioritize to strengthen WHO’s support for the prevention and management of NCDs, including ensuring affordable access to essential medicines, early diagnosis, and continuity of treatment, particularly in fragile and resource-constrained settings? I thank you.
CHAIR: Dr Kluge, you have the floor.
DR HANS HENRI P. KLUGE: Thank you very much to the representative of Lebanon for the question. So I would like to refer to the signature initiative I propose on primary healthcare as an integrated delivery platform, number one, but also what I describe in my manifesto as the priority number two, which is the triple agenda of non-communicable diseases, communicable diseases and maternal and child mortality, because they represent 90% of the disease burden. So here I would propose first and foremost to go through the integrated primary healthcare platform. Unfortunately, I have a lot of experience in the WHO European region, because we have two wars raging, and what we see is that often the elderly people are left behind with NCDs. So it’s a phenomenal important question, because people are going to die often from preventable diseases like hypertension, like diabetes.
So we need, number one, strong primary healthcare and investment in the workforce. And number three, innovation. For example, in Ukraine, a lot of innovations happened to deliver medicines to the front line through drones. So technology here is also very important. Finally, we know what’s working.
The best buys, the quick buys. So we need the political will and determination. I would start with a baseline assessment in each country, because we know that, unfortunately, we are going backwards. Finally, on the medicines, access to affordable medicines is a cornerstone of universal health coverage. Our experience is that it’s very important to create a safe space and to have all players together.
In our region we have the Novel Medicines Platform. It is the only platform where we have Member States, patients, insurers and also the pharmaceutical industry to work together to equitable, affordable access of both essential and high-cost medicines. Thank you.
CHAIR: I shall now give the floor to Bahamas to ask questions.
BAHAMAS: Thank you, Chair. Small island developing states face structural vulnerabilities arising from geographical fragmentation, limited economies of scale, and disproportionately high health care delivery costs. Yet, these realities are not always adequately captured by traditional measures of national income or development. If elected, what concrete steps would you take to ensure WHO’s policies best reflect these vulnerabilities and deliver more equitable support for small island health systems.
DR HANS HENRI P. KLUGE: Thank you so much to the Bahamas for allowing me to speak about one of my passions, the small island development states. I have been leading for 10 years the small country initiative in our region where we also have 10 small countries and we actually invited regularly Bhutan, the Bahamas, the Seychelles. So this is a very, very important step towards equity. Number one, as I mentioned in my speech, from day one, I would appoint a WHO special envoy on the small island development states and then identify the mandate and the resources. The performance measure would be whether the Minister of Health of the small island development states are perceiving faster and more quality support from WHO.
Number two, I believe that there should be more islanders in WHO where I would build on the Pan-European Leadership Academy to tackle underrepresentation of all Member States which are underrepresented. And of course I would count on all of you of the small island development states to set the agenda. We know that the number of issues which you mentioned indeed, access to medicines, because purchasing power for one small island or ten small islands together is not the same. I want to commend here, for example, Mauritius for taking a lead on pooled procurement, which we have been doing in the European Region as well. So this would be, effectively and concretely, very high on the agenda, including looking at ways to hear your voice at the WHO governing bodies, because that’s something I’m hearing as well: that the capacity is not always there to be at the table when new policies are made, and then you have to live with those.
And I have a number of ideas on that as well. Thank you.
CHAIR: I shall now give the floor to United Kingdom of Great Britain and Northern Ireland to ask a question.
UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND: Thank you, Chair, and good morning, Dr Hans. Thank you for your detailed presentation. The UK’s question is about strategy and prioritization. Given the ongoing financial pressures faced by the WHO, what specific strategic choices would you make to ensure WHO remains focused on its core technical, scientific and emergency response functions? Thank you.
DR HANS HENRI P. KLUGE: Thank you. If elected Director-General, I would propose a compact between the Secretariat and the Member States. The compact as following: WHO becomes a lean organization, shrink to mandate, through a functional review led by the Member States. Remember what I told in my opening speech? A member state led process on stop doing things.
Everyone is very good in prioritization, but stop doing things is another question. And the other equation of the compact would be that the Member States then decide on the money, meaning the increase in assessed contribution, because this is the only way to defend the scientific integrity of WHO. We do have experience. It was very tough, very tough. I want to thank Dr Tedros here for his support when we had to do this exercise, cutting 25% in the last year.
But I believe we managed to tour the force. In a war with a lot of geopolitical tensions and wars, We succeeded that health is the last place where everyone was sitting and agreeing around the table. With the European Program of Work approved by all 53 Member States with three categories. First category, essential activities which has to be pulled off. Second category, the Member States agreed only if we have money.
And the third activity was being outsourced to partners like UNFPA, like UNICEF, through the UNAT [unclear] process. And remember, please, that the European Region is not the Global North. It’s 53 Member States, where, yes, there are 27 EU countries, the UK, Switzerland, but we have Central Asia, we have the Caucasus, Türkiye. So the Region is also the Global South. So I think this process was very helpful, and it was done through artificial intelligence.
In a couple of months, we had the input of 10 million people. Thank you.
CHAIR: I shall give the floor to New Zealand to ask questions.
NEW ZEALAND: Thank you. How would you protect consistent evidence-based WHO positions when major Member States exert pressure on the Secretariat or disagree with WHO’s scientific advice? Thank you.
DR HANS HENRI P. KLUGE: Thank you very much. Fortunately or unfortunately, I have the experience. So, you saw from my presentation that I started as an emergency doctor. What I learned is that the capability to respond to an emergency all depends on preparedness. So I would from day zero invest a lot, like I did in the WHO European region, in relationships with all Member States.
Trust is the most important political capital for a WHO Director-General. And the proof was there. I got a lot of beatings. A lot of beatings. Why?
Because I consistently refused to choose sides. I only choose the side of the vulnerable patient. But I was rewarded for it. In 2024, I was re-elected as WHO Regional Director by the 53 Member States. So I think this is very important: invest before.
Number one. Number two, the assessed contribution is very important. If you get to 50%, WHO will be in a much stronger position, so that no norms and no guidelines can be bent by a superpower or a particular donor. And as Director-General, I would definitely do my share. Finally I think if you look in history in what happened in the WHO European region probably one of the best things what happened was the establishment of the European Observatory on Health Systems and Policies.
It’s an independent partnership hosted by WHO with scientific independence, editorial independence paid by 18 governments who happily pay for it, both poor and richer countries, providing independent scientific evidence for countries to make hard policy choices. I would build on that model. Thank you.
CHAIR: I shall give the floor to Bangladesh to ask questions.
BANGLADESH: Thank you. So our question to our distinguished candidate is that you have emphasized the importance of a more integrated and networked WHO. So how are you planning to ensure that strengthening coordination across the headquarters, regional level and the country offices of the organization leads to greater responsiveness and tangible benefits at the country level? Thank you.
DR HANS HENRI P. KLUGE: Thank you, sir. Thank you. And please pass my very best regards, respectful to the Minister of Health, who I remember very well over, great bilateral at the Region Committee in Tumor Lesti. It’s a very crucial question. So, as I try to describe in my manifesto, if I would be elected Director-General, I would pursue three transformation shifts in the way WHO is working.
Number one: going from centralized expertise in the headquarters to giving priorities to national countries. What do I mean? I mean that with your support and guidance, I would reorganize the organogram of WHO headquarters according to national priorities because now several countries are asking or approaching WHO according to structures from the past, financial resources and institutional silos. The organogram has to reflect the national priorities, the common denominator number one. Number two: to go from what I call a hierarchy to a network.
Together with the region directors I would work very closely with the six region directors because I believe in strong regions and the WHO on expanding interregional collaboration, like we have been doing, for example, with Southeast Asia in the field of traditional and complementary medicine, that countries work together not only within the region, but worldwide. And finally, I would strengthen the national expertise. It’s not that all the WHO expertise is sitting in WHO Geneva or the six regions. I mean, during my campaign tour, It is amazing how much untapped potential in each single country. I came just from Cabi Verdi, a country who eliminated malaria, or Georgia, or Egypt.
What they’re doing, hepatitis C. So the expertise is sitting really in the countries. So WHO should facilitate this exchange, including with hubs of innovation and research. I believe if the ring builds, I was told I have one minute. I’m finishing anyway.
But it needs, of course, a leadership. Because every change is difficult. Finally, we did it in Euro, in the field of cancer, where we looked what WHO headquarter can do, and I must say that Jeremy Farrar was very helpful there, what the region will do, which is mainly risk factors, and what the countries will do. So it is possible, but you have to invest. Thank you.
CHAIR: I shall now give the floor to Chad to ask questions.
CHAD: Merci, Monsieur le Président. Thank you, Mr Chair. Good afternoon, Mr Hans. I would start with something which is very clear. I’m right in front of you if you’re looking for me.
On governance, we all know that patients are in one part of the world, drugs are in another part of the world. If you take Africa, 70 to 80 percent of drugs available on the African continent are imported. So the question is about the supply chain. I would like to know what policy would you promote to restore a balance in supply chain thinking
DR HANS HENRI P. KLUGE: Thank you very much for this vital question. I’m very impressed by developments in Africa. It was in Nairobi where there was the summit, and two days ago I spoke to Professor Alex [?], who is at the head of the African Medicines Agency. I am sure that in five, six years Africa will be capable of producing 15, 20 vital medications and also through joint procurement as well with the African Agency for Control and Prevention, African Medicines Agency. So firstly, it was important to create a market.
This is crucial. Secondly, to increase the trust of Africans in Made in Africa products. And there I had a very good discussion with the professor I mentioned about cooperation with WHO, but also with the European Medicines Agency. This is fundamental because there are only two continental agencies, the African and the European Medical Agency. Thirdly, technology transfer is crucial, but not also to have the licensing, but also to have the framework for regulations and also the legal framework.
As a Director-General, I will always be very outspoken on the point that everybody has to be able to have access to these drugs. No family must be plunged in poverty because one of its members falls ill. Thank you so much.
CHAIR: The lighting system tracking the 50-minute period will now be paused. I shall now ask the Secretary to merge the contents of the six receptacles into one and will continue with the selection of Member States to or associate members until the time available is exhausted. Each time a question is posed and the answer is provided, the lighting system will be activated to track the one minute period for the question and the three minute period for the response respectively. I shall now give the floor to Ghana to ask a question. The lighting system tracking the 50-minute period for the question and answer will be reactivated at the same time.
GHANA: Thank you. Congrats, Dr Hans Henri P. Kluge. I have a very simple question. I want to find out, as DG, what mechanisms would you put in place to help accelerate the key objectives of the Accra Reset.
Thank you.
CHAIR: Dr Kluge, you have the floor now.
DR HANS HENRI P. KLUGE: Thank you, Excellency. Thank you so much, my dear friend. And let me, I cannot speak about the Accra Reset before commending your president. Please pass him my greatest respect as a champion. We’re very much looking forward to his presidency as the African Union, really.
The Accra Reset, as I was mentioning, for me is not a slogan. It’s really a reality. So, point number one. I would ensure that WHO is strengthened to be a technical secretariat, hand in hand with the African Center of Disease Control, my older brother, Dr Jean Kaseya, to back up the national compacts by the Minister of Health and Finance. Because this is key, leading from the Lusaka agenda as well.
Number one. Number two, in the first month, if I’m Director-General, I would create a council of elders from the Global South meeting twice a year to continuously focus my attention on the Global South. Because you know how it is as WHO Director-General: whether we want it or not, we have a [unclear] call and firefighting. I want my attention to be constantly focused on the Global South, and not least the Accra Reset. Number three, full support to the task force dealing, and doing a great job, I think, with the global health architecture.
The countries have to be in the lead, and that’s why I speak about country first. For me there is no contradiction between country sovereignty and multilateralism. For me sovereignty means self-sufficiency in some time but there has to be a transition and there is where WHO can be helpful. And of course as the colleague from chat just was mentioning the self-sufficiency in the local manufacturing is key for the Accra Reset. So this would be a number of the points and then of course to work very hard with good relations with all other global health initiatives as I was mentioning to align not beside but behind so that there’s one plan one budget and one report thank you sir
CHAIR: I shall give the floor to India to ask question now.
INDIA: Thank you, Chair, for giving me the floor. Traditional medicine is a lived reality in many countries. It is also a fact that traditional medicine systems are part of formal health care for hundreds of millions of people worldwide. How do you see traditional medicine in your strategy as a means to attain universal health coverage globally? Thank you.
DR HANS HENRI P. KLUGE: Thank you very much. And first and foremost, Madam, please pass my very best regards to Minister Nada. He was very inspired. And actually, I say this in modesty, but I’m also proud of this, that I’m the only regional director who attended both WHO global summits on traditional medicine, twice in your wonderful country. The first time was at the side of the G20 in Gujarat, and then second time, of course, in New Delhi.
And I think it’s no secret, or maybe public secret, that one of my great mentors from your country is the special representative and special advisor to director general on traditional medicine, Dr Poonam Singh, who is a great teacher. So I know very well about Ayurveda, but also in China, I was recently in China, I was telling in Beijing, where I went to the community health centers and saw, and I think that’s the key issue, probably for the future, the integration, the integration that is not this medicine, and then there is the traditional medicine. It has to be integrated. I want to reassure you, I’m a great believer. No one needs to convince me.
And, of course, I have to give a credit to also the WHO European region, particularly Turkey. Every year, actually, in a couple of weeks, the first week of December, I will be in Antalya, in Turkey. Every year, I have great honor to be personally invited by the first lady of Turkey, Madame Emide Erdogan, for the World Conference on Traditional Medicine. The Anatolian medicine has a great history as well. And ultimately, what’s our role?
It’s evidence. So we need to make sure that the medicine is evidence-based, is safe and is affordable. I see that as the keys. I want to thank you, country, but also the other countries, because the European region is learning a lot. But we cannot close the eyes.
We did a survey. More than 50%, 5-0, more than 50% in the 53 countries in the European region are using some form of traditional medicine. [Remainder of answer unintelligible in source.]
CHAIR: I shall give the floor to Indonesia to ask the question now.
INDONESIA: Thank you, Chair. Dr Hans Henri P. Kluge. Indonesia attaches great importance to country support that is guided by national priorities. We note from your CV that in Europe you mobilise thematic and voluntary contribution while shifting resources closer to countries.
We also welcome your commitment to organise WHO around country priorities rather than institutional silos. Our question is, as Director-General, if elected, how would you ensure that country priorities continue to guide WHO’s work, given that a large share of its funding is earmarked? Thank you.
DR HANS HENRI P. KLUGE: Thank you. Thank you. First and foremost, I would like to thank your minister and previous ministers in Indonesia for all the support that we received, also when I was working five years in Myanmar, particularly during Cyclone Nargis. I was happy that I could reciprocate when I was in Myanmar, that I also sent some of our people to Indonesia after the tsunami. So we have a close bond.
Thank you very much for this great question. Country support, as you see from my CV, indeed is in my heart. I think it links with the overall situation of the financing of WHO. So number one, shrink to mandate, I would say. I would start immediately a functional review to decide really what is our core business, and especially what to stop doing.
And based on the exercise we did in the 53 Member States, we can do this in a couple of months through artificial intelligence. And then this is our value proposition. Number two, we cannot let go the increase of assessed contributions. We have to explain to the prime ministers that this is the cheapest way to get health security. It’s the cheapest way to get health security.
And after all, Member States decided in 2022. Number three, I strongly believe there is still potential in middle income countries like actually the chair, Minister [Tandin] Wangchuk from Bhutan mentioned even at the World Health Assembly on graduated plans for that one. Having said that I would also look by their friend at how we spend money because sometimes we focus on more money. I would give you one example, if you allow me. We are very proactive in our region on transformation through artificial intelligence.
In one year, we saved $1.3 million value of the hours of WHO staff cost through operational efficiency. We avoided $340,000 in licensing, not bought, by developing our own tools. And we saved 15,500 hours of staff time. I definitely would pursue a very brave but responsible transformation of AI on operation efficiency in the organization. So yes, we need more money, but I’m very comfortable.
We can do also our homework. Thank you, sir.
CHAIR: I shall give the floor to Pakistan to ask the question.
PAKISTAN: Thank you very much. Europe is home to many of the world-leading pharmaceutical companies, and you bring value, experience, and understanding of this landscape. So as DG, how would you leverage this experience to strengthen collaboration with the European governments and industry to promote technology transfer, local manufacturing, and affordable access to medicines and vaccines?
DR HANS HENRI P. KLUGE: Thank you very much, Excellency. Let me first start to say that I always tremendously enjoy to be with the ambassadors of Pakistan and Shanghai Cooperation Organization, learning a lot. So on this question, I want to make very clear that I stand to serve every member state of the organization, which my curriculum clearly shows. I have been educated by a father who is a surgeon and a mother who is a nurse according to a very simple principle. Every patient deserves equal dignity, whatever religion, ethnicity, conviction.
We have an initiative in the WHO European region. It’s unique. It’s called the Novel Medicines Platform, catalyzed by Norway under the Oslo Medicines Initiative. I want to appreciate this because it’s a problem for all countries. Access to affordable, equitable medicines.
And I was asking, why do they come to WHO? They’re more agencies with hard power. The answer was, WHO is the only organization who can create this safe space environment to get Member States, patients, insurers, and the pharma around the table. And the first thing we have to do, which is what’s happening in the PAPS, The pandemic agreement, very important, is to look what are the red lines and again to create trust and to hold the chief. I would hold all chief executive officers of the big pharma accountable and ask that they fly into Geneva one by one, like happened in the time of negotiation of the PIP framework.
I talked to the two ambassadors Jose Comanches from Mexico and Bente Hansen from Norway who were leading the PIP framework negotiations successfully that time. And they all came in. Because yes, access to innovation is important. But the most important is that public health innovations reach the most vulnerable. It cannot be that pharmaceutical interests decide on who gets medicines or not.
And I want to take advantage to tell that the first operational priority for me would be advancing and implementing the pandemic agreement and the PAPS framework. That never again geography decides on who gets a vaccine or not. There you have my words. Thank you.
CHAIR: I shall give the floor to Italy to ask a question.
ITALY: After the difficult budget realignment and the related restructuring 2025 and with presumably flat budget for the next biennium, you will be elected to lead an organization having less resources than the recent past. And now, for multiple reasons, choices of discontinuation of activities remain fragmented and the narrative about what has been deprioritized is still unclear. Doing the same with less appear risky strategy, how do you intend to clarify and better articulate the deprioritization narrative to make it fully understandable to Member States and to make the related impact and trade-off more explicit.
DR HANS HENRI P. KLUGE: Grazie mille, amigo Dr Giovanni. It’s so great to see you here. This is one of the most crucial questions. And absolutely, I agree. More with less, same with less.
This has no credibility. From the very beginning, when I had to lead the 25% cut, My motto was different with less. It’s about a new business model. And I will give one very concrete example. I always like to be concrete.
We established the Istanbul hub in Turkey with the administrative and enabling functions. And again, I have to thank. I have no other choice to thank Turkey because they gave very good conditions. With the same money, we increased 32% of the staffing. So with a little bit of innovation, leadership and, very important, staff association support.
And I want to comment here the European Staff Association because we have gone a long way. A lot is possible. Increase of the AC remains so important. I salute Dr Tedros for this. I think this is historical leverage.
But we cannot do it without you, the Member States. Again, it’s the cheapest way to have health security and not to have lockdown in your countries. Then shrink to mandate. We need to, as you say, Dr Giovanni, decide, Member States, with our support, what are we going to stop doing? Or it doesn’t mean we don’t do it, but we give it to someone else.
I was sitting with UNICEF on the Mental Health for Children. I was sitting with UNFPA and UN Women. On women’s rights and health who does what we have to sit together and it’s possible because everyone safe faces the same and then to do over as I said to get our own house in order I mean this is a fact that I think a great job has been done by double-H.O. To survive and with the budget but we still have not started to look at a duplication between headquarters and the sixth regional offices, there is a tremendous potential there as well. And finally, we need to spend the money wisely, quality money, because for this biennium the budget will be fine globally, but there are these pockets of poverty like emergency preparedness which are not financed.
Thank you.
CHAIR: I shall give the floor to France to ask a question.
FRANCE: Thank you, Mr Hans Kluge. You mentioned PABS, the treaty, the agreement was adopted, the PABS is being negotiated. If adopted, how will WHO accompany states in operational implementation of the pandemic agreement and the PABS annexed? Thank you.
DR HANS HENRI P. KLUGE: Thank you, France. I’d like to congratulate you, Ambassador, and thank you for all your efforts. As I noticed in the last few weeks, I’m convinced that we have never been as close to an agreement. We will be very rigorous in implementing the instruments that you have agreed upon. I know that each and every sentence counts and that you expect from a DG, I think, most importantly, trust.
DG must be the custodian, somebody who will support you in implementing the agreement. So what is important? It’s important to support you with transparency that everybody, all the countries, must know what industry gives to countries. We need transparency, full transparency. So transparency, first and foremost.
Secondly, that everything that’s decided upon, that it will really follow up on it. We’ll monitor what happens because transfer technology, which is just on paper, It’s not genuine technology transfer. So transparency being very stringent that everything is followed up on and that everything is in order. And as a DG, always to ensure equity. This is crucial.
I think that’s Dr Tedros DG. He should be commended for this truly. Because he has faced a very difficult, the most difficult period in decades, and he always ensured equity. And lastly, always providing the latest evidence, scientific evidence-based data once again. Thank you very much, France.
CHAIR: I shall now give the floor to Islamic Republic of Iran to answer the question.
ISLAMIC REPUBLIC OF IRAN: Thank you Mr President. Thank you Mr Kluge. In light of the universal right to health, I would like to ask for your views on WHO’s plan to play a more effective role in ensuring unimpeded and equitable access to health products for all Member States. Thank you.
DR HANS HENRI P. KLUGE: Thank you, Excellency. And let me first and foremost recognize the self-sufficiency of your country. I’m always very impressed when I’m listening to the interventions at the meetings of the Shanghai Cooperation Organization, be it on medicines or on organ transplantation. This is a key element. I describe it clearly also in the manifesto.
Equitable access to vaccines, medicines, both essential and more expensive innovative ones that reach the most vulnerable, and also diagnostic tests. So on the vaccines in the time of pandemic, we just had the question of the pandemic agreement. But of course, there’s not only vaccines. As I was mentioning, I was speaking to the leadership of the African Medicines Agency. Where we have to look at medicines as basic antibiotics, active ingredients, etc.
So I would strengthen that team, really. That was one of the teams that I would strengthen in WHO headquarters, because at least two ministers told me that they were waiting for support on maturity level number three. So each region has to be self-sufficient. In my view, there’s no other way. So this has to be locally and regionally manufactured really.
And there WHO can do a lot, be it on regulatory frameworks, on legal frameworks, helping to create the market, training and capacity building. Very concrete example, Professor Alex from the African Medicines Agency was telling, listen, WHO should help us quickly that we in the continent can produce 15, 20, 30 of the essential medicines and the WHO prequalification can focus on the more complicated medicines. So in a graduate phase. But this is definitely a top priority. And finally, to create the trust by the people in locally made medicines.
And of course we cannot close the eyes for the unfortunate wars which are happening all over in the world. That’s another key element. And I want to salute, really. I want to salute all the health workers working in the circumstances. I myself went six times under the drones to the front line in my region.
There we have to be very innovative, like I mentioned, for example, the drones and other ways. Thank you, sir.
CHAIR: I shall give the floor to Slovenia to ask a question. Sorry, Slovenia. Hello.
SLOVENIA: Yes, I’m sorry, I didn’t quite get it at the first time. So our question would be: our experience with social participation has demonstrated that successful approaches developed in one region can also be highly relevant and valuable to others. So my question is, what concrete steps do you intend to take to strengthen the development and exchange of innovative solutions and good practices across WHO regions? Thank you very much.
DR HANS HENRI P. KLUGE: Thank you. Thank you so much to my beloved Slovenia. And please pass my very, very best regards to Madam President and the first spouse, who is a champion in childhood obesity. We are very blessed. And of course, for your amazing efforts to get a resolution on social participation.
Remember, I mentioned it in my opening speech. I was mentioning there Thailand. So it’s clear that I’m very, very committed to social participation, not at least in prevention. For the prevention, if in many regions we have aging population, which I don’t see as a problem. On the contrary, it’s a big success.
But the problem is that people are aging not in good health. And we need prevention also for financial sustainability, and there we need the people on board around the prevention agenda as co-creators of their health instead of just being passive beneficiaries of health services. And Slovenia has many good examples with the youth. So I think I have proven my commitment: when I had to cut down and make really very tough and bloody choices, social participation survived, because I really believe in this, just as I believe in collaboration with civil society, youth, NGOs. I’m a great believer in youth.
I see it with my two daughters, who by the way are members of the Youth for Health network, so I have no choice than to be very active in that field. So I will do this through inter-regional collaboration. It’s the second major transformation I mentioned of the three that I would pursue. And definitely, and I probably haven’t spoken about this, make use of WHO collaborating centres. My friends, we inaugurated the first WHO collaborating centre on social participation and youth health in Slovenia recently.
So definitely one of the first things I would do is come to you to sit down and make a plan with the other co-sponsors. Thank you.
CHAIR: I give the floor to Poland [as heard: “Pauline”] to answer a question.
POLAND [NAME RENDERED AS “PAULINE” IN SOURCE]: Thank you very much. So, dear Hans, given the WHO financial constraints, the Secretariat cannot do everything. Which areas or activities would you deprioritize as a Director-General and why? We heard your idea about the working group and what not to do, and that’s a good idea. But as a Member States, we rely on your guidance, your advice.
So what would you advise us to prioritize? Thank you.
DR HANS HENRI P. KLUGE: Thank you, thank you so much. To be honest, I learned my lesson because it’s very difficult if you have 53 bosses. I tried this and then you have always a boss of the 50, but why cannot cut that one? So it’s a very difficult exercise. So what I learned is that probably a WHO Director-General should provide you with some criteria, right?
Rather than to fields. So the criterion for me is the one that my very respected friend, the chief medical officer of the United Kingdom, Professor Chris Whitty, always tells me, WHO should not do what is important. WHO should do what only WHO can do. And of course I’m obliged because of the great question to give a little bit more meat. I always do my homework.
This is my respect for you. I was studying a lot 10 days before, including the constitution of WHO. And of course, we are the directing and co-ordating authority on international health work, but the constitution does not say we should do only normative work or only operational work. It even foresees for an operational role in emergencies if the country is asking. But of course, there are a number of global public goods.
Number one, norms and standards and guidance. This is WHO. Number two, international health regulations. Because remember, only WHO has a treaty making mandate on health and normative function. Coordination of surveillance.
This is so key to keep the world safe. And, of course, technical assistance to countries which are asking. Because I want to make something very clear and repeat from my manifesto, that any efficiency would go to low-income countries, fragile states, small islands. So it’s not that those countries have to be concerned that they will be weakened, on the contrary. So this would be the framework.
But again, we can be innovative, like in the field of NCD management. At that time, we had agreed with Jeremy. You do the very specialized care, because it’s not possible for six regions to find a top cancer specialist in all six regions. I mean, what can you do with one? So let it be here in headquarter.
And we do the risk factors, tobacco, alcohol, physical activity, obesity, linked with primary health care. And then the countries are assisting the national authorities. So I would advise it in a matrix. Thank you.
CHAIR: I give the floor to Azerbaijan to ask a question.
AZERBAIJAN: Thank you. Thank you. Thank you very much. Thank you, Mr Kluge. I welcome you.
And I just would like to ask you, you said the organization from within. So you have a very huge experience. And my question would be, if you elected, how would you transfer your regional experience into the worldwide approach? And what would be your daily activities, daily management and administration of the organization taking into account your previous experience? And what are the changes you foresee in the organization?
Thank you.
DR HANS HENRI P. KLUGE: Thank you very much, sir. In my very best regards to my friend, Dr Timur Mosayev, who has been promoted. Congratulations to Vice Prime Minister. So I’m very proud of this. On this one, first and foremost, I would like to reassure that I would stand to serve every member state of WHO.
We have a focus on the low income, fragile states, small island development states, but serving every country. So that’s number one. Number two, so I would never copy paste, let’s say, successful reform, but with you, adapt it to all region specificities. So what I would do, many things, but let me say two. One, immediately I would convene a retreat of the Executive Board, but with the six Regional Directors, to really look at the processes by which we are governing WHO, including on the management.
This is number one. Number two, on the staffing, I would go for a new regulatory human resources framework adapted to the 21st century, and it will include, for example, number one, to install mobility. Member States have already approved mobility. It’s up to the Secretariat. It’s very helpful.
I have been moving every five years with my family in life to the most difficult places on earth, and I believe if I’m sitting here, it’s because I have this field experience. Number two, upskilling the current staff, yes, in artificial intelligence, but more important in emotional intelligence, to break the silos. Your success is my success. My success is your success. And number three, to attract staff from other disciplines.
I was having long discussions with two great mentors, Professor Peter Piot and Professor Muyembe from DRC, on Ebola. The key issue is trust by the community. We need people, sociologists, anthropologists, right, to work with the communities. Because emergency is rarely only about disease. It’s about people, trust and resilience of the local health services.
Finally, I would reassure that there is geographical spread, also gender, very important, but always keeping in mind that I have action plan to increase the voice of the global south, including with the Council of Elders, more evidence, analysis, financed, be it on the African CDC, Fiocruz in Brazil, the Indian Council of Medical Research, right, there are, and decentralize those centres of excellence. Thank you, sir.
CHAIR: The time allowed for the question and answers is now exhausted and so is the total time allotted for the interview I thank you dr. Klo for being with us today and I would ask the Secretary to accompany you out of the room. This concludes this morning’s session. We can suspend the meeting and reconvene at 14 hours.
Afternoon session
CHAIR: Good afternoon. The meeting is called to order. So, proceeding with the next interview, may I please verify that all delegations have received the envelope with the two tokens for the afternoon session. I see that all delegations have received, so we will proceed now. We can now proceed with the interview of Dr Gevorg Tamamyan.
I shall ask the Secretary to bring the candidate to the podium. Good afternoon, Dr Gevorg. Welcome to the First Candidates Forum for the election of Director-General. I wish to thank you for coming to this interview today. I understand that the Secretary has already informed you of the way we shall proceed this afternoon, and I propose that we start immediately with your oral presentation.
Dr Gevorg, the floor is yours.
Interview of Dr Gevorg Tamamyan
DR GEVORG TAMAMYAN: Thank you very much. [Mr Chair] of the Executive Board, Excellencies, ladies and gentlemen, colleagues, people of the world. In 2018, I wrote about a young girl whose voice I still hear: “Doctor, do something. Help me. I don’t want to die.” She was screaming on the phone, and I could not give her the care she needed.
She died in pain. I have carried a question ever since. Would her story have ended differently if she had been born somewhere else? Today I’m running for that girl. Geography must not decide who lives.
I’m running for the people who could be saved but were not because they didn’t have resources or money. I’m running for the community health worker in Africa who covers a whole area as a volunteer and her son, Joshua, a young boy with those smart eyes. I’m running for them. I’m running for the woman with cervical cancer who has been waiting three months for radiotherapy and still has no idea when she will get it. And I’m running for the frontline doctors and nurses who died during COVID, not because there was no vaccine, but because it had not reached the place where she worked.
And I’m running for the extraordinary people of WHO came here to make the world a better place and now struggling in systems that too often stand in their way. Some of them are evacuating patients under bombardment right now. The world does not know about those heroes. You may ask who is this guy for your question. I’m not a WHO insider.
I have never worked at WHO. I have never run a ministry. Many people call me the outsider. But I’m not the first one. Harold Varmus was a cancer researcher who had no ministerial background before becoming the director of US NIH and led an agency-wide reform.
Maurice Pate was a businessman and humanitarian who became the first executive director of UNICEF and helped build into a global organization. And Kerry Adams, who many of you know, came to UICC from banking and he has done a great job. We all come with different experiences and I believe the real question is what we can do with those experiences. You already have candidates who know WHO extraordinarily well. My experience is different.
I have had to make health systems deliver where failure has consequences for actual patients. With limited resources, but with wonderful team and have built institutions, I led international networks and societies with the same energy, belief in humanity and equity, radical transparency and accountability. So let me tell you what I have done. In 2015, I went back to Armenia from Boston, determined to build one of the best pediatric cancer programs. People told me, you are naive.
You will not get resources. You will meet resistance, a lot of obstacles. They were right about almost everything except one thing. It was extremely difficult, but we did it. We centralized the care, trained a new generation of specialists who became champions in the field.
We established a foundation which has covered the diagnosis and treatment for every child and young adult up to the age of 25 for already nine years. Two years ago, the WHO team visited Armenia. They reported to the ministry that we had built one of the best pediatric cancer teams and services in the whole post-Soviet area. Today, that team is transferring the knowledge through WHO to several other countries. When she was admitted to our hospital, she was 11 years old.
A beautiful girl in a horrible condition, not able to eat, not able to drink, not able to walk. She had a tumor at the base of her school that could not be removed and was not responsible for responding to chemotherapy or radiotherapy. The only solution was to try a medicine which was not for that tumor. But there was one published case report showing promise in this tumor type. And I said, we are going to do it.
I remember my colleagues, my friends, great physicians were telling me not to do it. It is not going to work. It would only put her through more suffering. And they had a point. It was a risk.
But doing nothing was also a decision. And I know what that decision would mean for her. And I said, no. If there is even a little chance, we must try. And I did.
In one week, she was able to walk, eat and drink. In four weeks, she went home without any help. I share this not because I’m special. Everything I have done was possible because someone gave me a chance and because of the wonderful teams who did the work with me. I tell you this story because every day somewhere in the world health workers face impossible decisions.
We need a WHO that stands behind these people, that gives them the knowledge, tools and the support to make difficult decisions and the chance to save lives. Three years ago, when we were starting OncoDaily from zero, no one could believe that it would become one of the largest platforms in the world. For a long time, we had only one part-time employee and many volunteers. We registered the company in the U.S. I watched a five-minute video on YouTube on how to register it and did it myself.
Why the U.S.? Because, unfortunately, the world treats people not based on merit, but based on geography. And if I did it in Armenia, people would start questioning, oh, a platform in Armenia, what is it going to be about? Anyways, in three years, it grew into a company with around 80 people now. And one of those wonderful team members is our Ellen, an extremely talented young oncologist.
I met her first time when we were organizing leadership classes for medical professionals. Ellen was a student when she came. She applied for a scholarship for those classes. I still remember she was sitting in front of me and said, I collected all my scholarship money, it’s around $15 a month, during the whole of medical school. But it was not enough to cover the tuition, so she was applying for scholarship.
So Ellen later on became one of the first leaders of OncoDaily. Her team is close to 30 people now. And now she is setting up the first Phase 1 clinical trial unit in Armenia. She is in her 20s. During the Euro meeting in Copenhagen, several of you met her.
She was accompanying me to help. This is what happens when you give the young a chance. And the opposite is also true. When an organization restructures and lets its young people go first, it lets go its own future. WHO cannot afford it.
When I started traveling the world to seek a nomination, I asked an AI a question. Alone, with no country behind me and no diplomatic ties, what is my chance of being nominated outside my own country? The AI replied, zero. I think AI also thought that I am naive. I went anyway, and I stand here nominated by Botswana as the only cross-regional candidate in this race.
Because there are people who challenge the status quo. President Boko and his team were those people who made it clear that the passport is irrelevant when we are speaking about the health. And I am forever grateful to them. So am I naive? I am an optimist.
And I’m an optimist with the plan. I’m not naive. A plan you see in front of you in the program. And this is outside also there. Similar way I plan for Pediatric Cancer Center.
With clear goals, ownership and measurable and meaningful results. This plan starts with bringing WHO back to its roots. And I don’t mean the norms and standards convening power. Those are the tools. I mean humanity.
And in practice, humanity means one thing: saving lives. That is the core mandate. Everything else serves it. The program has three pillars: WHO for people, WHO for countries, WHO accountable for results. It has 12 commitments, each one measurable.
And it has one personal pledge: if I deliver less than 80% of those commitments, I will not seek a second term. What gets measured, gets done. I met many of you and most of the time you were telling me we want to politicize WHO. So I’m running to give you that chance. I cannot offer any member state a vote in return in another election.
And you know that. I ask only that every candidate in this race is judged by who they are and what they have done. My fellow candidates are remarkable people. Look at their work. And I’m running also for every candidate in this race so that no one feels they lose and everyone wins.
I’m running for my family, whom I see rarely and I miss them a lot. I’m running for my wife, who sacrifices her own career of a doctor to support me and who is here today. And my two beautiful daughters, whom I miss seeing grow and they tell me, Daddy, don’t travel anymore. But I’m running to make the world a better place for them. And for my parents who worked day and night and taught my sister and me to be better humans, and for every person who was kind enough to give me a chance that they see even a small act of kindness can change the world.
I have nothing else to offer you but determination to serve humanity, integrity, listening and making things happen. I don’t belong to any major or minor power. I offer to belong to each of you and to every human being. Thank you. Thank you.
CHAIR: Thank you. We will now continue with the questions and answers. I shall now invite Member States and associate members wishing to ask the candidates a question to place their white token in the receptacles corresponding to their region. May I please ask the Secretary to collect the tokens and to display the relevant tokens on screen. Done?
I shall now pull one token from each of the receptacles following the order of regions previously determined, starting therefore from the region of Americas. Once six tokens, one per person, have been pulled out, I will invite the corresponding Member States or associate members to ask questions.
SECRETARY: Paraguay. Kingdom of the Netherlands. Indonesia. I wonder who it will be. Thailand.
South Sudan. Pakistan
CHAIR: Thank you. That will be given the floor to ask questions in the third round are Paraguay, Netherlands, Indonesia, Thailand, South Sudan, and Pakistan. I shall now give the floor to Paraguay. To ask a question, the 50-minute period will begin simultaneously with the activation of lighting system. Paraguay, the floor is yours.
PARAGUAY: Thank you very much. Thank you very much, dear Chair. The region of the Americas has an institutional framework that is specific in which PAHO carries out functions as an independent organization as well as a regional office for the WHO. It has both functions. Regardless of this, the countries of the region contribute to the WHO, as all other member countries do in our region and other regions.
In line with this, how would you guarantee that this specificity, this institutional specificity, be protected and is reflected in the process of allocation of funds to the region. We wouldn’t want to have levels of financing that would be lower for the region. And generally, how would you make sure that there is equitable distribution of the resources of the WHO amongst all the different regions, taking into account their respective needs, capacities and vulnerabilities. Thank you very much.
CHAIR: Dr Tamamyan, you have the floor.
DR GEVORG TAMAMYAN: Thank you very much, Your Excellency. Equity is my career and is my life. I mean, it’s the basic of my career. So, I mean, I’m coming from a small country affected by wars and hardships. So I know what equity means.
About the, and that’s why it’s critically important for me, whatever we do, we do having that in our mind. And I think WHO supports, it should go based on the need. In one place, if there is a much need, we need to go there. But it doesn’t mean that if we go there with a big group, we need to stand there all the life. It should fluctuate in my opinion, and it should be need-based.
Regarding the PAHO, I think there are a lot of things we need to learn from PAHO. And, I mean, PAHO, of course, it was before the WHO, but, I mean, there are a lot of these procurement schemes and the helping the countries this way. And I think there are things that we can certainly learn, and this is a strong region through the PAHO. About the distribution, I think I answered your question, that I’ll do my best based on the equity. I hope I answered your question.
CHAIR: I shall give the floor now to Kingdom of the Netherlands.
KINGDOM OF THE NETHERLANDS: Thank you, Chair. Thank you. Thank you for the presentation. Our question is: Considering the current pressure on WHO, how do you plan to safeguard the scientific independence and standard-setting role of WHO, specifically related to its work on sexual reproductive health and rights and climate and health. Thank you.
DR GEVORG TAMAMYAN: Someone asked me why WHO needs a physician scientist at its head. And I answered “physician” because we need physicians urgency and scientists to defend the science. I am a scientist, so science for me is very important. Certainly, there are, if I am not mistaken, 260 million deaths, maternal deaths every year. So there is a huge work to be done.
And we are going to work with the countries, show them the most evidence, what is available. They are the decision makers. We need to show them the evidence. But I think as a human being, and as a physician, every woman must have the ability to have an access to care and be treated with dignity. Regarding the climate, I mean, we have great experts in this race who are climate experts.
So certainly, first of all, I’m going to ask Dr Neira about the climate. But the overall idea is, I mean, it’s the reality and we need to face the reality. And we need to make sure that whatever happens, there is a heat or flood, the patient with cancer receives the medication, the woman who is going to deliver a baby is able to get to the hospital. So the continuity care is very important. And we need to, I mean one size does not fit all.
The changes in South Sudan is different than the changes in the small islands. And in small islands also, every single one is different. So one size does not fit all. I think we need to work with the countries to understand, taking this as a base, what we can do together. Here I would mention also, I think it’s around 19 countries right now, they are served from the shared offices, WHO offices.
But I was talking to many of the countries and they want more, they want more presence. And we need to, I mean, this is continuation of the answer I gave to the previous question. It needs to be needs based. Does not mean less important. We need to make sure that we have people there, we need to have WHO presence there.
And I will make sure that every single country which wants presence gets it. Thank you.
CHAIR: I shall give the floor to Indonesia to ask questions.
INDONESIA: Thank you, Chair. Thank you, Candidate. We share the view that the WHO must focus to deliver results. Results. Yet agreeing on priorities among Member States is often the hardest step.
Your vision states that WHO cannot do everything and that unfunded mandates weaken execution. Our question is, if elected as the Director-General, what process would you use to facilitate members’ agreement and what particular area would you propose to exercise this? Thank you.
DR GEVORG TAMAMYAN: I agree with you and thank you very much. Indonesia has a great candidate as well and I’m honored to be running with him and we had a very nice discussion with him recently. For sure we need to have focus to deliver the results. And when we say something and we don’t do that, the trust is eroding. The trust is gone when we say we will do it and we don’t do that.
That’s why we need to be careful about the promises and about our resolutions. I cannot make all the decisions myself. WHO is first of all the Member States and Secretariat is just serving the Member States. But I will make sure that working with the Member States for every single resolution we have a real plan and plan includes the delivery, the evidence, the delivery, who is responsible, how it is funded, and how we are going to follow up. Because if we just make resolutions and it doesn’t work, it’s weakening us.
That’s number one. Number two, which one we need to step back? And I think it’s a very hard question, but it’s a hard question to discuss with the Member States again. I’m not going to make a decision alone, and it’s not my decision, but I’ll make sure that I show which one works, which progress there is, to show you, our Member States, what is really working, and you will make a decision. And the third one, I think it’s very important that we recognize that time is also a finite resource.
So whenever we do any resolution, it takes a lot of time from our staff preparing all this, and we need to make sure that we use the time as a finite resource, more precious than money. Thank you very much. I hope I answer you.
CHAIR: I shall give the floor to Thailand to ask questions.
THAILAND: Thank you Chair. Our question to the candidates is that in your speech you said the world just people by geography, not merit. So our question is that what are the concrete measures that you would like to take so that more qualified experts from low and middle income countries lead the political programs, the technical networks and also the Global Health Initiative. Thank you.
DR GEVORG TAMAMYAN: Thank you so much. So important really. And thank you for asking that question. First of all, I think it starts from myself. My door is always open to the talent.
And I never, try to never, miss the opportunity to talk to the people, to understand who they are and how they are coming. I talked about this intensively and many times, but I think the reform also should start from the HR. It’s unacceptable that it takes, like for two years, important position is getting vacant while there are so many talented people all over the world. Many people all over the world who can get this position. But because of bureaucratic hurdles we are not able to fill it.
To institutionalise what we can do, especially for bringing the talent, first of all, the doors will be opened for everyone. But also, we are going to publish, starting from the top, who are the people getting hired, from which regions, gender, and all these criteria, so that we make sure that the equity is in place. It’s just not the words, but we have it. For me, I have been trained and worked in seven countries, And I mean, everywhere I went, I was met by open hands. And I got the best treatment.
So I know that the talent exists everywhere. We just need to make sure that we don’t let them down. And I mentioned in my speech, especially the young people, which currently only 0.6% of the staff is below 30 years old. Thank you.
CHAIR: I shall give the floor to South Sudan to ask questions.
SOUTH SUDAN: Thank you, Chair. Your trust in public health institutions has eroded to some extent globally. How will you reform the WHO’s risk communication strategy so that scientific guidance is transparent about uncertainty without fueling misinformation or public skepticism? So that is my question. Thank you very much.
DR GEVORG TAMAMYAN: Thank you very much, Your Excellency, and thank you also for advice. I borrowed this word “saving lives” from His Excellency and thank you for giving me that advice, because I was pushing on humanity, but he mentioned humanity means saving lives. So thanks. Trust in my opinion is earned through delivery, through radical transparency and accountability, number one. I’m a pediatric oncologist.
I had these discussions, the most difficult discussions ever and so one can imagine with people, with families and telling them that unfortunately we can’t do anything and their child is going to die. And the only thing which is helping during that discussion, The firm belief that you are doing everything, you are transparent about it, you stick to the science and you do your best. But most importantly, on the scientific side certainly, we need to defend the science and we need to do it transparently. That’s our core mission, one of the core missions. But we need to communicate it much better.
We need to make sure that people get this information in different ways now they exist. I think this is one of my strengths, the communication. Because I have built also, besides being a pediatric oncologist, I have built also a communication platform basically from zero, which in a short period of time became one of the world’s largest ones and reaches millions of people. So I think I have some knowledge on how to communicate better and certainly we need to make sure that WHO communicates better based on science and based on the best available evidence. But I would add also something.
It’s very important for the Trust to be able to say we were wrong. We made a mistake. This is critically important. This is part of the transparency. We make mistakes, we just don’t cover it some way like with some diplomatic words.
No. We say very directly this was wrong because in medicine, in healthcare, we may make a lot of mistakes and this is a part of the whole system. Thank you very much.
CHAIR: I shall give the floor to Pakistan to ask a question.
PAKISTAN: Thank you. Thank you, Chair. Our question to the candidate would be regarding a particular situation that affects our region, the eastern Mediterranean region. Many countries in our region carry a double burden. They host large displaced populations from conflicts in their neighborhoods, and they face recurrent climate disasters, all under heavy debt and shrinking aid.
How would you ensure predictable support for such countries’ health systems and keep WHO impartial and responsive to the priorities of all the regions? Thank you.
DR GEVORG TAMAMYAN: Thank you very much for the question, Your Excellency. I’m well aware about the situation in Eastern Mediterranean region because I have been working in that region and I was entrusted by colleagues and elected by colleagues to lead the pediatric oncology Eastern Mediterranean region for a few years. And it’s like 28 countries including Pakistan and 110 cancer centers. So partially I’m aware about the situation. Unfortunately, we live in the time where there are wars, where there are displacements, and also the climate change.
But let me take the answer to the other angle. Look, the cancer patient, and sorry that I’m bringing this example, the cancer patients, I just don’t want always to focus on cancer, but you can take any patient. The cancer patient in displaced area, in the area affected by war, yes, they are double heat because when the war starts or there is a displacement, the priorities are changing. But we need to make sure that those patients are not left behind. When I was doing my capstone project in Harvard, it was focused on patients in war-torn areas.
Unfortunately, at that time when we were publishing, there were not that many experts in the field, because it was not that big problem. But unfortunately, it’s getting more and more and more. And I was behind the summit. Me and my team were organizing the first summit on global, a global summit on war and cancer, where Dr Tedros also made an opening. And we made a resolution published in Lancet.
But it takes a lot of time and energy to make these things work. And we need to work with these countries to make these changes practical. Because I also feel that this resolution, we need to make sure it’s practical. It’s not just a resolution and every year we start coming and telling, okay, this is important. We need about the impartiality.
I’m also coming from the conflict-affected region, as you know. And my country has been affected by wars for three decades. But we need to talk to every single side of the conflict to be able to make these corridors that people who need care, they receive the care. We need to be able to protect the healthcare, that the healthcare does not become a target.
CHAIR: The first six questions are read out and answers given. The lighting system tracking the 50-minute period will now be paused. I shall now ask the Secretary to merge the contents of the six receptacles into one and will continue with the selection of Member States or associate members until the time available is exhausted. Each time a question is posed and an answer is provided, the lighting system will be activated to track the one minute period for the question and three minute period for the response respectively. I shall now give the floor to United Kingdom of Great Britain and Northern Ireland.
And the lighting system tracking the 50-minute period for the question and answer session will be reactivated at the same time
UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND: Thank you chair this question is about leadership of a large organization how would you translate your clinical and academic experience towards leading an organization of WHO’s scale and complexity.
CHAIR: Dr Tamamyan, you have the floor.
DR GEVORG TAMAMYAN: Thank you very much, Your Excellency. Thanks for this question, for bringing that. My experience is not only clinical. Yes, I have been leading Cancer Center, and I led the consolidation of Cancer Center. Also, I mentioned that I established a global platform, which became one of the largest one in the world.
Besides that, and the research institute, but besides that, also, I was elected by my peers across Asia, the whole continent, to lead the Asia continent for International Society of Pediatric Oncology. But within two years, we were able to find and nominate 45 country ambassadors. And it’s not about the numbers. Within that short period of time, the Asia continent became not just the largest one within the society, but one of the most active ones. This is just one example.
I was elected by my peers to lead pediatric oncologist and Mediterranean group from North Africa to Asia, and with 28 countries and 110 cancer centers. And I think we did a good job there. And I was selected also and asked to co-chair the European group for Senjude Global Alliance with 13 European countries. I am really honoured that I was entrusted with my colleagues to lead these organisations and societies. And I think we have done a good work.
Of course WHO is big, but leadership, I think, is the same, smaller or bigger. The principles are the same.
CHAIR: I shall now give the floor to Mexico to ask the question.
MEXICO: Muchas gracias. Thank you very much. Dear candidate, how could the WHO under your leadership provide concrete support and quantifiable support to the national priorities of middle-income countries such as Mexico? They are working on universal health coverage, on the strengthening of primary health care, as well as equitable access to medicine, innovation, as well as a reduction of inequalities in health. How will you be able to help them?
Thank you.
DR GEVORG TAMAMYAN: Thank you very much, Your Excellency. Thanks for this question. One of the concrete steps I mentioned already, that the presence should be needs-based. And we should talk very transparently with the countries to understand what their needs are and our presence should be based on that. Of course I understand the complexities and the constraints, but I am sure the countries will also be willing to host more of the WHO’s presence.
In my opinion, we should move more to the countries. That’s why one of my pillars is WHO for countries. So those functions can be hosted in the countries, we should move there. Because it’s the 21st century, it’s not the 20th century, and a lot of things change. So certainly we can do a better job also by decentralizing.
Regarding helping the national priorities, of course we need to use all our power, convening power and I mentioned this also during the Berlin, we are going to take the phone when you need the help and we are going to come there when you need our help. Because WHO is first of all the Member States. One thing you mentioned about innovation and it is very close to my heart. I don’t want Global South to be seen as a place where innovation lands, and it is not like that. Global South is a place where also innovation is born.
But we need to make sure to make that possible. During the COVID, Omicron was found out by scientists in Botswana and South Africa, and then they stayed in the line to receive the vaccine. We need to make sure that this doesn’t happen again. Can I guarantee that it’s not going to happen? I cannot.
But I can guarantee that I will not do my best that it doesn’t happen again. And there I would need your help, everyone’s.
CHAIR: I shall give the floor to Spain to answer the question.
SPAIN: Thank you very much. How do you understand the participation of the World Health Organization in the transition of the UN AIDS program, given the fact that WHO is one of the six main co-sponsors? How do you see this transition happening? Thank you.
DR GEVORG TAMAMYAN: Thank you very much, Your Excellency. I think it’s good that I’m getting questions from the countries where there are great candidates. In any kind of international process, in my opinion, and I don’t want to get into these details because I am not an expert on this, and I will make sure that I will ask advice from the experts. To continue also in the previous question on the leadership, I am not going to lead alone. I am going to, from the first day, to make sure to bring the top UN and WHO experienced leadership into the leadership team.
So I will make sure that it happens. But in any international process, WHO is there. If there is a health component, we should be leading because WHO is the Member States, first of all. And WHO was created by the Member States to lead. So we need to make sure we are there with our top talent there.
Sorry for not being specific, but that’s my answer.
CHAIR: I give the floor to Singapore to ask a question.
SINGAPORE: Thank you, Chairman. Thank you very much for your presentation. May we ask for your views for your priorities and vision for WHO’s role in strengthening the global pandemic prevention, preparedness and response efforts? Thank you.
DR GEVORG TAMAMYAN: Thank you very much, Your Excellency. Thank you for bringing that question. It’s difficult to answer when there are great experts in the room who are right now negotiating the pandemic agreement and sitting right now in front of me. But let me give you my overview on that. We should be prepared before the pandemic comes, before the panic begins.
I think I’m not saying something innovative about this, but this is the core. And we need to make sure, when we say prepared, we need to make sure that it’s measurable. What does it mean prepared? In Berlin, I’ll give you one example. In Berlin, I gave this example about the WHO Academy.
The best possible emergency simulation center. I mean, the lights should not get off in that place. Because the simulation center should do training every single hour, because that’s what we need. WHO already has these great programs. We need to make sure they work and they are in place, the 717 and the other ones.
I am full of hope that by the time, if I am elected, By the time the agreement and annex already are implemented, are accepted by the Member States and so we’ll go to help the implementation. But one thing I must mention and it’s in my core belief that whatever we do it should be equitable. Those who are sharing should not wait at the back of the line. It should not happen again that the countries receive vaccines with three months’ expiration date. Thank you.
CHAIR: I shall give the floor to Guinea to ask a question.
GUINEA: Thank you very much for the excellent presentation. You’ve never led an organization similar to the WHO. How can you reassure Member States about your capacity to manage and reform WHO? Thank you.
DR GEVORG TAMAMYAN: Thank you very much, Your Excellency, for that question. Yes, I have never led WHO. I am not coming from WHO. I am not a WHO insider, I am a WHO outsider. But I have built institutions in the places where the decisions of WHO were making consequences for the patients.
I have that experience. In the race we have great candidates who know WHO the best. My experience is different. And I’m not the only one, as I mentioned in my speech. They are great leaders, and they were great leaders, coming with similar histories, not leading big organizations, but then leading countries and institutions.
Several of them I mentioned, the former NIH director, and also some of big organizations, including the UNICEF former director. So I’m not the only one. There are also country leaders, but I’m not going to mention them. Many of them know them very well. That it’s not kind of, I don’t give kind of favor to any country.
But I think in many of the countries, you know great, great leaders who have done great job without leading in that scale. And I know my strengths and weaknesses and I’m not going to learn the building alone, as I mentioned. I’m going to make sure to have with me a top talent and to ask the top talented people to join me in leading the organization. Thank you very much.
CHAIR: I shall give the floor to Barbados to answer the question.
BARBADOS: Thank you Chair. This question relates to health workforce sustainability. Caribbean countries continue to experience significant health workforce shortages compounded by international recruitment of nurses, midwives and healthcare professionals. What specific actions would you prioritize to strengthen implementation of the WHO Global Code of Conduct in the international recruitment of health personnel, promote ethical recruitment and establish meaningful support mechanisms for countries disproportionately affected by health workforce migration. Thank you.
DR GEVORG TAMAMYAN: Thank you so much. This question really is so close to my heart. I have my podcast called World Health Voices. When I invited one of the ministers like a year ago from the small island states, I think, to the interview, he said, I don’t want to interview, we don’t have oncologists come work with us. So I know that there is a big problem and it exists.
But I have also experienced in our small country right now, the rate of pediatric oncologists for 100,000 or so. I think it’s now higher than the United States. We trained in a small profession, but with all the difficulties, we had zero brain drain. All our doctors, nurses, everyone, all the doctors had also training outside the top institutions and all of them, they came back. I think it’s working together to make sure that how we keep the talent inside.
Because I mean I cannot guarantee that like, because I mean it’s also their right to choose where they want to go. But we need to make sure that we make sure that we make conditions for them to stay. And I’m happy to work and our country offices should be, the first work of the country offices should be working with every single country to address the health workforce. Because the healthcare, first of all, it’s the workforce, healthcare professionals, doctors, nurses, midwives, community health workers, everyone. So we should be able to do that.
There is a big gap, like a million, 11 million, I think there is a number. So we need to close that gap. And we will be able to do it, I’m sure. Especially with the current technologies of transferring the knowledge and many other tools. We will be able to do it.
I’m very positive on that side.
CHAIR: I shall give the floor to Brazil to ask a question.
BRAZIL: Dr Tamamyan, good afternoon. If elected, how do you plan to reconcile the promotion of innovation with the need to ensure affordable and equitable access to essential health technologies, particularly in developing countries, including through intellectual property policies and technology transfer? Thank you.
DR GEVORG TAMAMYAN: Thank you so much, Your Excellency, for bringing that question. I’m going to continue what I said about the innovation, but from a different angle. There is no miracle drug in the world if it’s not accessible, or there is no miracle technology in the world when patients don’t have access to it. But I think together we need to make sure also that the, so this is about equity, but about the other part, the innovation. Because my speech was 10 minutes, I had to cut part of it, but there was a line why I’m running.
I’m running also for the innovators who are getting hurdles and obstacles because of bureaucratic systems. Because I know it very well in oncology that because of bureaucratic systems, innovation sometimes land on the shelves and never get to the patients who could be saved. And there are so many stories about this. When someone just because of the persistence they brought back the innovation, which later on saved millions of lives. We need to make sure to work with the countries.
And it doesn’t matter low income, high income, middle income, with every countries, to make sure that innovation happens faster. Because again, it’s 21st century. The time is, for me, it’s like, you know, I have this, maybe it’s like, again, from my profession, but this urgency. I mean, I can’t stand when we treat the time in a so luxury way in general. And it’s also about the innovation.
We need to make sure to support as much as we can, how much we can, bringing people together to understand what are the problems in different countries to foster this innovation. When I was founding, establishing research institute in Armenia, the clinical trials, it was four years ago, the clinical trials, there were only three cancer clinical trials in Armenia. And I think one of them even was suspended or so. In four years, we trained great talent and we were able to multiply, I think four or five times the number of clinical trials in Armenia. And we also started global registries, where I think 20 or 30 countries now are contributing.
But most importantly, also working with the ministry, we were able to make sure that the Registration of clinical trials right now is close to one month, if I am not mistaken, which in Loweming Dalmica country is a great result. Thank you.
CHAIR: I shall give the floor to Saudi Arabia to ask a question.
SAUDI ARABIA: Thank you very much, Chair. Thank you for your presentation. You mentioned in your presentation that some describe you as an outsider and you also repeated this again. And given this experience, how would you address WHO’s sustainable finance issue that is currently facing the organization? Thank you.
DR GEVORG TAMAMYAN: Thank you very much, Your Excellency. Yes, I am an outsider, that is true. But there are exceptional insider candidates, including Dr Balkhi from Saudi Arabia. I think it’s the decision of Member States to decide. Right now, at the time of the WHO’s history, do we need insider or outsider?
But I think it’s not about it. We need to work all of us closely, including for the financial things, including for the other matters. And for me, let me answer a little bit different way and I’ll come back to the finances. Two days ago I was in Beirut, Lebanon, visiting the Ministry. And I was so happy when the Minister mentioned they have a great cooperation with the Regents and the country office.
And I remember, I think, during the EMRO meeting, that the Minister mentioned that we are going to follow what WHO says. I think it was a great signal. So we are certainly going to work with the regions. And if elected, I would certainly need also regional support, including the regional directors, including for finances. But let me be clear on the financial side.
In my opinion, finances never matter. It’s about the impact. If there is an impact, we are able to show the impact. Finances will come. That’s from my experience.
Small or medium, but that’s from my experience. I built the institution where no one believed on that. And also I built a platform, maybe not that scale, but currently I think it’s quite a big platform with quite a big valuation. But from zero, literally zero. We had only one part-time employee, a great student from India, because his English was the best one.
I gave also some examples on how we can bring finances, including the foundation, WHO Foundation. Of course it is an independent foundation, but we need to work on that. The cancer center I was trained, the budget is several times more than WHO’s budget. The phone we are holding, we never ask why we pay $1,500 or $2,000, we just pay it. We don’t go and buy $100 phone, because we see the impact.
It’s never about finances. We will be able to bring the finances. And I’m sure Saudi Arabia also will help there and other Member States as well. Because you will see the impact and together we will make the impact. And when you see the impact, the finances will come.
Send Your Children’s Research Hospital raises $3 billion a year. Three billion almost, two and a half or three billion. In one country only. How we cannot do that? We should learn from the best experiences.
And we will be able to do that, I’m sure. Thank you very much.
CHINA [INFERRED, FLOOR-GIVING NOT CAPTURED]: President, I would like to thank Dr Tamamyan’s presentation. We noticed that in your presentation, you stressed the role of WHO in identifying the priorities. If you are elected, how would you define these priorities? How would you discuss with the Member States?
DR GEVORG TAMAMYAN: Thank you so much, Your Excellency. I was in China a few days ago and had a great time there, honestly. And I’m grateful I was attending the China Anti-Cancer Association Congress. And before knowing that you have a great candidate, I’m very grateful that they endorsed me. So I was happy to go there again.
And the role of WHO, I don’t think it’s to identify the priorities, it’s the role of the Member States. I should make sure, just as a WHO Director-General if I liked it, to build the best team, who can deliver, who can make the things happen, to do it transparently, radical transparency, and with the equity at the bottom of my heart. I think that’s the answer to that question. Thank you.
CHAIR: I shall give the floor to Malaysia to ask a question.
MALAYSIA: Thank you, Chair. Member States have agreed to increase their assessed contributions to WHO with expectation that WHO will become more transparent, efficient and accountable. As DG, what specific measures or reforms would you introduce across WHO three levels, headquarters, regional offices and country offices to prove value for money and to demonstrate clear and tangible results.
DR GEVORG TAMAMYAN: I give an example. As the head of the Pediatric Cancer Centre, every year on February 15, I would stand up, it’s the International Childhood Cancer Day, and report publicly what I have promised, what I have done. And if I didn’t do anything, why? It’s the same principle. I’m going to bring that principle.
And I’m going to suggest to the regional directors and also ADGs that director general, ADG and regional directors together report to the Member States every year publicly what has been promised, what has been delivered and why it didn’t deliver or we didn’t deliver. The other thing, very important, I think, I mean any big or small organizations, majority, have these minutes. When we are having meetings, we record the minutes and we put it online. Do we have these minutes? If we have, it’s good.
If we don’t have, we need to. I think we don’t. The leadership team every month should meet with the public minutes published. Of course, if there are some issues we need to be protected, it will be. But in general, this should be discussed publicly.
So we need to make sure that we do everything, whatever we do, we do transparently. And we show the results. My programme, I have all the commitments with the measurable results. And most importantly, I have a personal pledge, as I mentioned. If I don’t deliver, I’m not going to run again.
And this will be assessed not by the team appointed by myself, but by the executive board. Thank you.
CHAIR: The time allowed for the question and answer is now exhausted. And so is the total time allotted for the interview. I wish to thank Dr Tamamyan for being with us today. And I would ask the Secretary to accompany you out of the room.
DR GEVORG TAMAMYAN: Thank you very much everyone. Thank you, Your Excellencies.
CHAIR: While the Secretary is accompanying Dr Tamamyan out of the room and Dr Li Song is being brought in, I would like to ask the delegations to remain in their seats so that we may begin the next interview as soon as the next candidate is here. Good afternoon, Dr Li Song. Welcome to the First Candidates Forum for the election of Director-General. I wish to thank you for coming to this interview today. I understand that the Secretary has already informed you of the way we shall proceed this afternoon, and I propose that we start immediately with your oral presentation.
Dr Li Song, sorry for the delay. You have the floor. The 10-minute period will begin simultaneously with the activation of the lighting system.
Interview of Dr Li Song
DR LI SONG: Thank you, Mr Chair. Your Excellencies, Ministers, Ambassadors, Ladies and Gentlemen, Good afternoon. It’s a great honor to be here with all of you. While we sit here during the 10 minutes of my speech, five women will die from pregnancy-related causes. Ten people will die from HIV-related causes.
Most of these deaths are preventable. So here is the question that brings us together here. If these deaths are preventable, why do we still allow them to happen? To me, these are not just numbers on the page. As an obstetrician and gynecologist, I have welcomed new lives and have shared the joy of their families.
I have also risked against time to save women with cervical cancer and comforted patients and families. As a policymaker at China’s Ministry of Health, I led national maternal and child health care programs. Over the last 25 years, China’s maternal mortality dropped 75 percent from 53 to 13.4 per 100 thousand live births. This experience taught me a simple truth: mortality falls when policy It empowers a functioning health system. My mission is to bring these proven blueprints to the most vulnerable health systems worldwide.
At the Our China Women’s Federation, I work with nearly 80,000 staff serving 700 million women and girls. Advanced gender equality and sustainability by promoting health, education, digital literacy, agrotech and small businesses, helping lift 44 million women out of absolute poverty. I have joined over 100 collaborations with WHO, UNICEF, UNFP and many other global partners. I have served on WHO expert advisory groups, so I know how to turn WHO’s technical documents into national action plans. This experience has taught me that global health is measured not only by guidelines, but by whether evidence translates into better health for people.
Career has been defined by bridging clinical medicine with national policy and national policy with global solidarity. This is the collaborative leadership I promise to bring to WHO. In my conversations with national leaders, advocates and experts, I hear three concerns time and again. Firstly, a shared expectation that WHO focuses on its core mandate, broadens its funding base and ensures every dollar is well spent. Secondly, countries expect WHO to strengthen pandemic preparedness and improve access to medicines, vaccines and essential health services.
Thirdly, all Member States, big or small, want their voices heard and their needs considered. They especially hope to strengthen primary health care and respond to climate-related health threats. Dear Delegates, if elected, I will make WHO more effectively, accountable, equitable, consultation with all Member States with four priorities. The four E’s: Efficiency, Awareness, Equity and Empowerment. Firstly, Efficiency.
Efficiency is not about doing more. It is about doing what matters most effectively. WHO’s three must work together and deliver as one WHO, mobilizing global expertise and strong technical leadership. Let’s streamline procedures, clarify responsibilities and hold ourselves accountable for measurable results. Secondly, our readiness.
Today’s preparedness determines tomorrow’s survival. We must advance the revised international health regulations and the pandemic agreement, helping the most vulnerable countries build core capacities. We will help Member States strengthen emergency response capacity for prevention, surveillance, early warning and response, especially in low and middle-income countries. Above all, we will ensure rapid, sense-based and coordinated action when crisis strikes. Thirdly, equity.
A tree can only flourish with strong roots. As we work toward universal health courage, we must strengthen primary health care, maternal and child health, non-communicable disease care, immunization, mental health and services for aging population should reach every community. Services need to be affordable, accessible and of good quality. We will promote local production of vaccines, diagnostics and medicines and help vulnerable countries build climate resilience. Global health is long-distance risk.
Roots ahead can share its experiences. Those behind need a helping hand. Fourthly, empowerment. Innovation should be a bridge, not a divide. It should connect people to opportunities, not drive them apart.
By scaling up digital health, telemedicine and artificial intelligence. We can address health workforce shortages and close the last mile of care. As innovation advances, governance must keep pace. We will safeguard data security and privacy, confront misinformation and ensure AI is used responsibly. Ladies and gentlemen, let me share a personal experience.
Twenty years ago, in a remote mountain village, I met a young pregnant woman and her husband, both living with HIV. Seeing her break down in despair, I hugged her and said, “Don’t give up. With treatment, you can have a healthy baby.” She burst into tears, and her husband grabbed my hand. At that moment, I saw a light of hope in their eyes. They later had a healthy baby.
I sincerely hope that more families, no matter where they live, in a remote island, in the crowded cities, or in the rainforest, can all have their healthy babies? Going back to the question at the beginning, why do we still allow these preventable deaths to happen? The truth is, we don’t have to. The power to make positive changes in people’s lives lies in our hands. We speak different languages and live in very different situations.
Yet, we share the same aspiration for health. WHO must listen. It must deliver. And above all, it must achieve results. Keeping people’s concerns at heart and turning promises into results.
This is the responsibility I am ready to take on. I stand ready to work with all of you to lead WHO and build together a healthier, safer and more equitable world. May every life be protected. May health for all become a reality. Thank you.
CHAIR: Thank you. We will now continue with the questions and answers. I shall now invite the Member States and Associate Members wishing to ask the candidate a question to place their green token in the receptacle corresponding to their region. May I please ask the Secretary to collect the tokens and display the relevant token on screen. I shall now pull one token from each of the receptacles following the order of the regions previously determined.
Starting therefore from the Europe region, the six tokens, one per region, have been pulled out. I will invite the corresponding Member States or associate members to ask questions.
SECRETARY: Belgium Australia. Australia. Kenya Pakistan Brazil.
CHAIR: The six Member States that will be given the floor to ask questions in the fourth round. I shall now give the floor to Belgium to ask a question. The 50-minute period will begin simultaneously with the activation of the lighting system.
BELGIUM: Thank you, Chair. Dr Li Song, you have called for a more efficient and focused WHO. Where would you look first for opportunities to reduce complexity and simplify WHO’s ways of working in practice?
DR LI SONG: Thank you. Thank you. Thanks, Your Excellency. About your question, yes, in my speech, one of my priorities, if elected, that is a high efficient WHO. So for WHO, the three levels from the headquarter, the regional office and the country office should deliver as one WHO to serve for our Member States.
So we shared the same goal: the attainment of the highest level of health for all. So we need to work together to deliver the outcome for our all Member States. And according to WHO, the core mandate, more focus on the global guidelines, norms and standards in the making. And from the different levels, have the different very clear responsibilities. Will be one of the measures for the regional level needed to coordinate the Member States in the region to have a coherent collective action to serve for all Member States.
And for the country level, the WHO country office needs to integrate the CCS, the country cooperation strategy, with the Member States national health plan, well, alignment, so that WHO can provide the high efficiency of their serving for Member States. And also, to simplify the WHO workflow, my plan is to use the emerging technologies such as artificial intelligence. At the beginning, the microphone couldn’t work well. So I think maybe in the future we can update the innovative methods and use the AI to empower the WHO, to empower the staff, to empower Member States so that we can simplify the workflow and improve our work efficiency. Thank you.
CHAIR: I shall give the floor to Australia to ask a question.
AUSTRALIA: Dr Song, thank you very much for your very clear presentation just now. The Director-General must uphold the WHO’s constitution, decisions and scientific advice. Sometimes this will differ from the preferences of some Member States. My question is how you would manage such disagreement and demonstrate the independence of your office. Thank you.
DR LI SONG: Thanks, delegates from Australia. It is a very important question. As Director-General of WHO, the principle, I think it is critical if elected as Director-General. There are three key principles. First, the scientific independence.
Second, the evidence-based decision-making. The third is the transparent process. As Director-General of WHO, should abide by the WHO Constitution, Nations Charter and the rules of procedure as well as code of conduct for staff members. And WHO should serve for all Member States, not serve for one single country. So to keep neutrality, that is the baseline.
And for WHO, there are many expert groups to provide adversary. So I think WHO in the future needs a diversified, broadened representatives W2, the expert group, just as I am now the member of W2, the advisory group expert for the maternal and children, the adolescent health. So all Member States’ voices need to be heard. All Member States’ considerations need to be respected. So in the future, I think especially those underrepresented countries need more involvement in WHO’s technical adversary group.
Because WHO provides globally the scientific evidence and the co-mandate global guidelines, norms and standards making, so we need the diversified representatives based on competence, merit and geographic representative. Thank you.
CHAIR: I give the floor to Bangladesh to ask a question.
BANGLADESH: Thank you, Chair. So, Madam Candidate, my question to you is, how do you ensure that WHO’s technical cooperation model MOPS beyond the transfer of expertise and technologies towards building sustainable local capacity strengthening national institutions and reducing long-term dependence on external assistance. Thank you.
DR LI SONG: Thanks, Your Excellency. Just as I mentioned, in the future, if elected as Director-General, I will strengthen the country-level capacity building, especially according to Member States’ priorities, expectations. For those resources-limited countries, African countries, the island countries, the Latin American countries, and developing countries, global source countries, recent In the last few days, I discussed these issues with the delegates about the local production for those countries. So for WHO, we need to help Member States together to strengthen the country level ability. So for WHO have a very good mechanism, the MPP, the medicine, the patent pool.
So we can coordinate all kinds of stakeholders to sit at the same table. We encourage the voluntary license so that the more Member States, the resources limited countries can have their ability for the essential health supplies for their people to avoid. When the emergency disease happens, they couldn’t access the necessary medical supplies, such There are vaccines, diagnostics and therapeutics. So I think for WHO, can also coordinate more stakeholders to provide the mechanism, the procurement mechanism, and also for the stockpiles, etc., to help more Member States, especially those developing countries, can equally access the essential health supplies and make a better preparation for the next pandemic, so they can have affordable, available, acceptable and quality vaccines, diagnostics and therapeutics.
CHAIR: I shall give the floor to Kenya to ask a question.
KENYA: Thank you very much Chair and thank you very much Dr Song for your presentation. As you know in Africa right now in the DRC we have the ongoing Ebola outbreak and our heart goes out to the people of the DRC. As the Director-General my question to you would be how would you uphold the international health regulations and keep borders open especially where evidence does not support closing them, especially through public assessments of consistency with Article 43 of the IHR.
DR LI SONG: Thanks, Your Excellency. Just as your concern, this is also my concern. In recent months, I pay attention to the Ebola outbreak in the DRC. So my heart is also with the people who are living in DRC. And my many colleagues just returned from the front line to support the DRC, the health workers, staff, the colleagues together to fight against Ebola.
So according to the international health regulations, we need to mobilise more resources to support the affected countries, to help them to have the ability for the pathogen, the surveillance, and also need to have a very good risk communication and also have a close engagement in communities with health workers together. And the information sharing among the affected countries together for WHO to provide the more technical support to mobilize the more resources to support these affected countries to know their actual situation, such as if they lack the essential diagnostics, therapeutics. So we need to provide the necessary timely health supplies, the medicines for our people who are suffering from the Ebola outbreak. That will help these affected countries to have the essential medical supplies to fight against the Ebola outbreak and have a very good control. Also, I show my highest respect for colleagues, staff of WHO and other international agencies.
At present, at this moment, they are working in the front line, in the communities, to help the affected countries together to fight against the Ebola outbreak. Thank you.
CHAIR: I shall give the floor to Pakistan to ask a question.
PAKISTAN: Dr Song, thank you for your very comprehensive presentation. With your long experience in maternal and child health and China’s impressive strides towards universal health coverage, what key lessons would you bring to WHO to help developing countries with limited resources to advance UHC, particularly through primary care? Thank you.
DR LI SONG: Thank you. Your Excellency, this question is critical for the SDG3, the health and well-being for all human beings, especially universal health courage. So we need the two very key measures. The first to strengthen primary health care. From my working experience, we need to provide the timely and quality health service for our people who are living in communities, villages and remote areas.
So we need to strengthen primary health care. The health system seeks blocks: the information system, the finance, and the qualified workforce, and also the medicines, and the basic health services, and effective governance need to be strengthened for primary health care. So that we have the skilled, the midwives, doctors, nurses can provide maternal health care for pregnant women and skilled health workers to provide the vaccination for our children in the community. In the future, from my working experience, I will help Member States together to strengthen primary health care, especially the health system strengthening the community health centers, the village clinics, the township hospitals. The second part is the financial protection for our people.
We provide the hospital delivery subsidy. Then later we provide hospital delivery freely for all pregnant women. So we need to help Member States to have the fiscal insurance system strengthening to reduce the catastrophic health expenditure, especially for those families to reduce out-of-pocket health expenditure. We used only 10 years to improve the health insurance from 20% to 95% of the universal health coverage, the health insurance system. So I believe with all of the work together, we can protect our people.
The universal health coverage, leaving no one behind. Thank you.
CHAIR: I shall give the floor to Brazil to ask a question.
BRAZIL: Good afternoon, Dr Song, and thank you for your presentation. If elected, what concrete measures would you take to expand the participation of developing countries in WHO’s decision-making processes, technical staff, and leadership positions? Thank you.
DR LI SONG: Thanks, Your Excellency. At the beginning, I mentioned that we need to have a diversified and broad representatives into the WHO technical guidelines making, especially from developing countries. So in the future, according to the WHO’s rules of procedure to select the more expert based on the competence, the merit and expertise. So we need to provide the more opportunities for more representatives from the different regions, the different Member States to work together. Just as I work for WHO, the advisory group of experts on maternal children, the health.
I work with different countries’ representatives together. So in the future, WHO also needs to help those developing countries have the capacity and to provide the more training opportunities and also in the governing bodies, the more developing countries’ representatives to involve in the decision-making process, the global guidelines, norms, standards, the making, the process. For those countries have the very precious asset of the scientists, the experts. So in the future, if elected as Director-General of WHO, I will, according to the selection, the rules of procedure to invite some more representatives from the island countries, African countries, global South countries and developing countries, and they have the ability, they can have their voices, suggestions to involve in the global guidelines, norms, standards making. Thank you.
CHAIR: The first six questions are read out and answers given. The lighting system tracking the 50-minute period will now be paused. I shall now ask the Secretary to merge the contents of the six receptacles into one and will continue with the selection of Member States or associate members until the time available is exhausted. Each time a question is posed and an answer is provided, the lighting system will be activated to track the one-minute period of the question and the three-minute period for the response respectively. I shall now give the floor to Bahamas to ask the question.
The lighting system tracking the 50-minute period for the question and answer session will be reactivated at the same time.
BAHAMAS: Thank you, Chair. Significant investment and proven intervention process in reduction of burden — sorry, process in reducing the burden of noncommunicable diseases remains slow, particularly in developing states. If elected, what new approaches would you champion to accelerate NCD prevention and control, and how would you ensure that small Member States have the support needed to translate global commitments into measurable and sustainable health outcomes.
CHAIR: Dr Song, you have the floor now.
DR LI SONG: Dr Song: Thanks, Your Excellency. About the NCDs and mental health prevention and control, I think we should pay high attention to this issue, especially for developing countries. Recent days I discussed a lot of issues with many delegates from Ireland countries, African countries and Latin American countries. The delegates told me that the NCDs, mental health, have bring a very heavy burden for their society, for their country. So we need to take the multi-sectoral cooperation for NCDs prevention and control.
For the NCDs, the mental health, have many social determinants, not only the health sector’s responsibility. Many years ago, I attended WHO’s guidelines discussion about the AHA, it is the adolescent health acceleration action. So for the adolescent mental health, we need to provide comprehensive measures. The health sector needs to have a very good cooperation with the education sector, the schools, and also to have a youth-friendly hospital, youth-friendly community, youth-friendly society, and reduce stigma for mental health. And also for NCDs, We need the health promotion to improve the people’s health literacy.
The healthy lifestyle should reduce the cardiovascular delays and hypertension, etc. So we need more body exercises together. So we need the multisectoral cooperation and the whole of society campaign to provide the health information for our people. From individual to family to community to society together for the NCDS and mental health prevention and control. Thank you.
CHAIR: I shall give the floor to Zambia to ask a question.
ZAMBIA: Thank you. Good afternoon Dr Song. My question is on maternal mortality rates. Your presentation shows the amount of work that you have done to reduce the maternal mortality rates by 75% from 2000 to 2025. My question is: If elected as Director-General, how do you hope to transfer these lessons learnt from your performance to countries that are still struggling with very high maternal mortality rates?
I thank you.
DR LI SONG: Thank you, Your Excellency. This is one of my concerns, because every two minutes, one maternal death. And every day, over 13 soaring children couldn’t see their fifth school. Birthday. So from my working experience, we need a functioning health system and we need the financial protection for our people.
So for WHO, we need to help Member States to strengthen the primary health care, the health workforce shortage in some countries. When I discussed this issue with many friends from Africa, my friends from Africa told me they don’t have the qualified doctors and midwives. So WHO needed to provide technical support for these countries, the more training opportunities so that they can have the qualified midwives, the doctors, so that they can provide skilled the birth attendant. And also for some countries, they told me the lack of the basic health supplies when they face the obstetric emergency. So we need to help these Member States to help them strengthen the obstetric emergency aid capacity.
And different countries have different actual situations. So that’s why I want to strengthen the country level capacity to work closely with the Member States together, according to Member States, the needs, the priorities together and to mobilize more resources. And in the country level for WHO, need to have a very good combination with national health plan together to provide the targeted, the technical support, according to Member States the actual needs. Thank you.
CHAIR: I give the floor to Egypt to ask a question.
EGYPT: Thank you, thank you chair. Thank you Dr Li. Speaking about the global health governance, what we see right now is under a great pressure from geopolitical fragmentation and declining trust between Member States just as we must implement the pandemic agreement, including fair arrangements for pathogen access and benefit sharing. In our region, many countries depend on the imported vaccines and diagnostics and polytransmission. Transmission presents in sum.
If you are elected as a director general, what practical steps would it take to rebuild trust among Member States and to ensure regions like ours gain timely access to countermeasures and the capacity to produce it locally. Thank you.
DR LI SONG: WHO. Thanks, Your Excellency for WHO. As a specialized agency among the United Nations, its core mandate is the global guidelines, norms, standards-making. So WHO needed to provide for Member States the solid, reliable scientific evidence and global guidelines so for Member States can have these tools to have a very good guidance for their health program implementation. Another mandate for WHO is the coordinating role when we face the emergency.
So at present, that is a very good opportunity for all Member States to work together. So if elected as Director-General, global solidarity is one of the important priorities. So I use my name, Dr Song Lee, the first character, as solidarity. So I will firmly strengthen global solidarity, especially when we face the PAPS annex negotiation. So I think for WHO, we need to provide the coordinating and convening function for member States so that in the future the PAPS annex can be negotiated and make consensus to reduce divergence among the Member States.
And that can be implemented as early as possible because we need to prepare for the next pandemic from now. No one country will be safe if the pandemic occurs. So we need global solidarity. And we need all Member States can equally access the essential medical supplies, the vaccines, diagnostics, and therapeutics, so that all Member States can fight against our human beings, the shared enemy that is the novel virus. Thank you.
CHAIR: I shall give the floor to Paraguay to ask a question.
PARAGUAY: Thank you very much. Dear candidate, how would you deal with the assistance that is provided to the Member States, especially to medium-income countries that are facing great health challenges? However, these countries have limited access to concessional funding as well as to international cooperation mechanisms. How would you help them? Thank you.
DR LI SONG: Thank you, Your Excellency. For the low and middle-income countries that face many health challenges for WHO. It is very important to work closely with the international partners together to support the Member States, especially the resources limited countries. One said We need to mobilize more resources so that we can have sustainable, predictable and flexible funds to support the resources-limited countries. So we need to diversify the resources.
WHO needed to work with other international partners, such as the multilateral banks, the philanthropists, and also, according to FNSA, have the public and private sector cooperation so that we can mobilize more resources to support the resources limited countries. And on the country level, I think it is very important to have integrated the resources integration to serve for Member States together. One plan, one budget, and one monitor and one evaluation, so that we can have the most cost-effective outcome for Member States. And also, I think, on the ground implementation, according to the Member States, the actual needs to provide the precise target support for Member States, especially to help Member States have their resources mobilization, their ability, by using external aid as a catalyst to mobilize more resources domestically. Health skills achieved.
It is not only the health sector’s responsibilities. So WHO can provide strong evidence for Ministry of Health, then Minister of Health can use the evidence. The $1 input then gain from the $35 for health input. So we can mobilize the Ministry of finance and other ministers together to work for health for all, leaving no one behind. Thank you.
CHAIR: I shall give the floor to Ethiopia to ask a question.
ETHIOPIA: Thank you very much, Chair. And thank you very much, Dr Song, for the presentation. You have told us about how emergency preparedness and response should be a priority and also global attention is often strongest during the acute phase of health emergency. So how would you ensure that WHO remains equally focused on recovery, restoring essential services and building stronger health systems after an emergency has passed?
DR LI SONG: Thank you. Thanks, Your Excellency, for the rapid recovery of some of the emergencies. I think we couldn’t wait until the emergency happens, then we provide the emergency aid. So we need to make a better preparation for the future. So that’s why I stressed in my speech the four pillars.
One priority is the ever readiness. So from now we need to help Member States, especially those fragile health system countries. From now, these countries can have a strong capacity for surveillance, early warning and emergency response. And for island countries, the climate resilient health system building and strengthening, it is very important. So from now, WHO needs to protect our people to make a better preparation for the next emergencies happen.
And also from the WHO, the headquarter regional level, we need to coordinate the more Member States to have the emergency medical team so that one country that face the natural disasters or some emergency events. So we can rapidly dispatch our emergency aid team to help that member state who is in the most needed. So if elected as Director-General of WHO, I will strengthen the regional emergency health aid team. And from now, we need to provide more training opportunities so that they are in functioning and they are ever ready for the most needed Member States according to their needs expectations. Thank you.
CHAIR: I give the floor to South Sudan to ask a question.
SOUTH SUDAN: Thank you, Chair, and thank you also for Dr Li for her presentation. My question would be, in an era of severe budget constraints, what two functions or programs or three that WHO currently perform that you would stop or hand over to other global health actors such as the World Bank, Gavi or the Global Fund. Thank you very much.
DR LI SONG: Thanks, Your Excellency. Just two days, the Global Health Architecture Intergovernmental Working Group discussion the global health reform. So about the WHO’s function, the core mandate and the partnership with other international partners. I think the priorities need to be considered according to the global situation, according to the Member States’ needs, the Member States’ priorities. So that’s why I stress that we need to integrate the WHO’s, the CCS, the country cooperation strategy with the Member States National Health Plan together to be implemented effectively, coherently, and for different international partners, have different comparative strengths.
From my working experience, to reduce the maternal mortality rate and under five children mortality rate, WHO has a very good partnership with UNICEF, UNFPA and World Bank. So from my working experience, I use W2’s global guidelines such as postpartum hemorrhage, reduction treatment. UNICEF can provide the intervention, the measures, and UNFP can provide the MISP, the service package for women. So World Bank can provide the financial support for Member States. So I think for WHO, have a very close cooperation with the international partners together toward the health for all.
And to let every partnership have their comparative strengths functioning. And serve for Member States, serve for people’s actual needs. That’s my answer. Thank you.
CHAIR: I give the floor to Mauritania to ask a question.
MAURITANIA: Thank you. How will you help people living in difficulties in humanitarian crises? How will you be able to protect women, children and people on the move that do not have access to essential services? How do you count on doing so?
DR LI SONG: Thanks, Your Excellency. This question is critical, especially for those vulnerable populations, the displaced populations and who are living in conflict areas. For WHO to provide the emergency health aid for those vulnerable populations. One side of WHO needed to mobilise more resources to support those vulnerable populations, especially As we know, the pregnant women couldn’t give birth safely. The children couldn’t access the necessary treatment.
So we need to provide the essential health service for those people. As I mentioned, every 10 minutes, the five women will die from pregnancy-related causes. WHO needs to have a very good cooperation with the other international partners, the International Organization of Immigration and ICRC together to take the collective action to provide the essential health services according to the international humanitarian law. And as we know, it’s better for those vulnerable populations, displaced populations, the essential medical supplies. So we should provide the equal essential health supplies for them.
Here I strongly call for peace. I strongly call for all related parties to end hostilities. Because all human beings, we are brothers, we are sisters, we are family, one family, live in the one planet, the Earth, our shared home. So I sincerely hope that may every life be protected and may health for all become a reality. Thank you.
CHAIR: The time allowed for the questions and the answers is now exhausted. And so is the total time allotted for the interview. I wish to thank you, Dr Song, for being with us today, and I would ask the Secretary to accompany you out of the room. This concludes this afternoon session and the first day of the first candidate. First Candidates Forum.
We will suspend the meeting and resume tomorrow morning at 9.30 a.m. Thank you.
Editorial note: Edited from automatic English-channel transcripts. Speaker labels were reassigned from the automatic diarization using the Chair’s floor-giving statements. Fillers, stutters and audio noise were removed, and names, acronyms and punctuation were corrected. Speakers’ own wording, including contractions, is preserved. Square brackets mark editorial insertions, translations, gaps and uncertain readings. Candidates’ remarks in Arabic, French, Spanish, German and Dutch are kept in the original language. This is not an official WHO record. Check against the WHO webcast before quotation.
Legal disclaimer: unofficial ad hoc transcript
This is an unofficial, ad hoc, clean verbatim transcript of the First Candidates’ Forum for the election of the WHO Director-General, held on 18 November 2026. The Geneva Learning Foundation (TGLF) produced it independently by editing automatic speech-to-text output from the English audio channel of the public webcast. This transcript was not created by the World Health Organization (WHO). WHO is not responsible for its content or accuracy. It is not an official record of WHO, the World Health Assembly or the Executive Board. No WHO official, candidate, Member State or other speaker has reviewed or endorsed it. The English channel includes simultaneous interpretation, which is not an authentic or verbatim record. For statements made in other languages, this transcript records the interpretation, not the original. Non-English passages appear as automatically recognized. English renderings in square brackets are informal TGLF translations, not WHO translations. Editing removed fillers, repetitions and audio artefacts, added punctuation, corrected apparent errors in names and terms, and inferred who was speaking. Because these steps involve judgement, the transcript may contain omissions, misattributions, mistranslations and other errors. Square brackets mark insertions, gaps, inferred speakers and uncertain readings. Only the statements as delivered are authentic, as preserved in the official WHO webcast and any official WHO records, which prevail in case of discrepancy. Do not rely on this transcript as an authoritative account, or quote it as a statement of any person, Member State or WHO, without checking the webcast. Naming a person, Member State, organization or position implies no endorsement of any candidate by WHO or TGLF. WHO does not endorse TGLF or this document. The WHO name and emblem may not be used in connection with it. This document is provided “as is”, without warranty of any kind, express or implied. Readers are responsible for how they interpret and use it. WHO, TGLF and the speakers accept no liability for damages arising from its use.
